<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2022.791802</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Effect of Autoinducer-2 Quorum Sensing Inhibitor on Interspecies Quorum Sensing</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Kai</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Yijie</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<xref rid="aff4" ref-type="aff"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Bo</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<xref rid="aff4" ref-type="aff"><sup>4</sup></xref>
<xref rid="aff5" ref-type="aff"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yue</surname>
<given-names>Yuandong</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Meihua</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Rui</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Hao</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Lei</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yuanyuan</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xiao</surname>
<given-names>Junhai</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<xref rid="aff4" ref-type="aff"><sup>4</sup></xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lin</surname>
<given-names>Feng</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
<xref rid="c002" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1508153/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>School of Life Sciences, Jilin University</institution>, <addr-line>Changchun</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Key Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, School of Life Sciences, Jilin University</institution>, <addr-line>Changchun</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>National Engineering Research Center for Strategic Drugs, Beijing Institute of Pharmacology and Toxicology</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>No. 971 Hospital of People&#x2019;s Liberation Army Navy</institution>, <addr-line>Qingdao</addr-line>, <country>China</country></aff>
<author-notes>
<fn id="fn0001" fn-type="edited-by"><p>Edited by: Rinarani Ray, Maulana Abul Kalam Azad University of Technology, India</p></fn>
<fn id="fn0002" fn-type="edited-by"><p>Reviewed by: Sougata Ghosh, RK University, India; Tung Truong, University of Pittsburgh, United States</p></fn>
<corresp id="c001">&#x002A;Correspondence: Junhai Xiao, <email>xiaojunhai@139.com</email></corresp>
<corresp id="c002">Feng Lin, <email>linfeng@jlu.edu.cn</email></corresp>
<fn id="fn0003" fn-type="other"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>791802</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>10</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>03</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2022 Jiang, Xu, Yuan, Yue, Zhao, Luo, Wu, Wang, Zhang, Xiao and Lin.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Jiang, Xu, Yuan, Yue, Zhao, Luo, Wu, Wang, Zhang, Xiao and Lin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Bacterial drug resistance caused by overuse and misuse of antibiotics is common, especially in clinical multispecies infections. It is of great significance to discover novel agents to treat clinical bacterial infections. Studies have demonstrated that autoinducer-2 (AI-2), a signal molecule in quorum sensing (QS), plays an important role in communication among multiple bacterial species and bacterial drug-resistance. Previously, 14 AI-2 inhibited compounds were selected through virtual screening by using the AI-2 receptor protein LuxP as a target. Here, we used <italic>Vibrio harveyi</italic> BB170 as a reporter strain for the preliminary screening of 14 inhibitors and compound Str7410 had higher AI-2 QS inhibition activity (IC<sub>50</sub>&#x2009;=&#x2009;0.3724&#x2009;&#x00B1;&#x2009;0.1091&#x2009;&#x03BC;M). Then, co-culture of <italic>Pseudomonas aeruginosa</italic> PAO1 with <italic>Staphylococcus aureus</italic> ATCC 25923 was used to evaluate the inhibitory effects of Str7410 on multispecies infection <italic>in vitro</italic> and <italic>in vivo</italic>. <italic>In vitro</italic>, Str7410 significantly inhibited the formation of mixed bacterial biofilms. Meanwhile, the combination of Str7410 with meropenem trihydrate (MEPM) significantly improved the susceptibility of mixed-species-biofilm cells to the antibiotic. <italic>In vivo</italic>, Str7410 significantly increased the survival rate of wild-type <italic>Caenorhabditis elegans</italic> N2 co-infected by <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923. Real-time quantitative PCR analysis showed that Str7410 reduced virulence factor (pyocyanin and elastase) production and swarming motility of <italic>P. aeruginosa</italic> PAO1 by downregulating the expression of QS-related genes in strain PAO1 in co-culture with <italic>S. aureus</italic> ATCC 25923. Compound Str7410 is a candidate agent for treating drug-resistant multispecies infections. The work described here provides a strategy for discovering novel antibacterial drugs.</p>
</abstract>
<kwd-group>
<kwd><italic>Pseudomonas aeruginosa</italic> PAO1</kwd>
<kwd><italic>Staphylococcus aureus</italic> ATCC 25923</kwd>
<kwd>AI-2 quorum sensing</kwd>
<kwd>ethylene diamine triacetic acid group</kwd>
<kwd>interspecies</kwd>
</kwd-group>
<contract-num rid="cn1">2018ZX09711003-003</contract-num>
<contract-sponsor id="cn1">National Science and Technology Major Project of China</contract-sponsor>
<counts>
<fig-count count="8"/>
<table-count count="3"/>
<equation-count count="1"/>
<ref-count count="64"/>
<page-count count="14"/>
<word-count count="9998"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>Introduction</title>
<p>Most bacterial diseases are caused by infection with multiple species of bacteria, for example, cystic fibrosis (CF) and chronic wounds (<xref ref-type="bibr" rid="ref25">Harrison, 2007</xref>; <xref ref-type="bibr" rid="ref16">DeLeon et al., 2014</xref>; <xref ref-type="bibr" rid="ref8">Blanchard and Waters, 2019</xref>). On co-infection by multiple bacteria, different strains interact with each other and contribute to the pathogenesis of the disease. The pathogenic mechanisms resulting from the interaction of multiple microbes are often different from those of individual species (<xref ref-type="bibr" rid="ref5">Baldan et al., 2014</xref>).</p>
<p><italic>Pseudomonas aeruginosa</italic> and <italic>Staphylococcus aureus</italic> are the two most important pathogens in <italic>CF</italic> and chronic wounds (<xref ref-type="bibr" rid="ref16">DeLeon et al., 2014</xref>; <xref ref-type="bibr" rid="ref8">Blanchard and Waters, 2019</xref>). Interactions between <italic>P. aeruginosa</italic> and <italic>S. aureus</italic> have been the focus of several studies on multiple-strain infections. Notably, <italic>P. aeruginosa</italic> significantly increased the production of <italic>S. aureus</italic> biofilms and resistance of <italic>S. aureus</italic> to vancomycin on co-culture <italic>in vitro</italic> (<xref ref-type="bibr" rid="ref60">Yang et al., 2011</xref>; <xref ref-type="bibr" rid="ref37">Orazi and O&#x2019;Toole, 2017</xref>). In a wound model co-infected by <italic>P. aeruginosa</italic> and <italic>S. aureus</italic>, the resistance of the bacteria to antibiotics was significantly increased, and the toxicity of <italic>P. aeruginosa</italic> was also increased (<xref ref-type="bibr" rid="ref15">Dalton et al., 2011</xref>; <xref ref-type="bibr" rid="ref16">DeLeon et al., 2014</xref>). Moreover, after co-infection by <italic>P. aeruginosa</italic> and <italic>S. aureus</italic>, the healing of pig epithelial cell wounds (<xref ref-type="bibr" rid="ref39">Pastar et al., 2013</xref>) and mouse wounds (<xref ref-type="bibr" rid="ref29">Korgaonkar et al., 2013</xref>) was significantly delayed, and <italic>S. aureus</italic> promoted the pathogenicity of <italic>P. aeruginosa</italic>. <xref ref-type="bibr" rid="ref29">Korgaonkar et al., 2013</xref> showed that peptidoglycan produced by <italic>S. aureus</italic> can significantly increase the lethality of <italic>P. aeruginosa</italic> toward <italic>Drosophila</italic> and promote the production of <italic>P. aeruginosa</italic> virulence factors such as pyocyanin and elastase. In the sputum of <italic>CF</italic> patients, <italic>P. aeruginosa</italic> and other bacteria, such as <italic>Streptococcus</italic> and <italic>Staphylococcus</italic>, can communicate with each other through the autoinducer-2 (AI-2) quorum sensing (QS) system (<xref ref-type="bibr" rid="ref19">Duan et al., 2003</xref>). This indicates that different bacteria in multispecies infections can increase in pathogenicity through QS.</p>
<p>Quorum sensing is a signaling mechanism that regulates the life activities of bacteria by transmitting signals through the synthesis, release, and acceptance of autoinducers (AIs). Bacteria sense the density of the surrounding population <italic>via</italic> AI molecules, and this regulates gene expression (<xref ref-type="bibr" rid="ref23">Gokalsin et al., 2017</xref>). AI-2 is an intra- and interspecies signal molecule &#x201C;a common language&#x201D; for bacterial interaction. AI-2 QS was first discovered and characterized in the Gram-negative marine bacterium <italic>Vibrio harveyi</italic> (<xref ref-type="bibr" rid="ref6">Bassler et al., 1994</xref>). Bioluminescence of <italic>V. harveyi</italic> is regulated by QS. <italic>V. harveyi</italic> produces AI-2 signal molecule through LuxS protease and after AI-2 binds to LuxP receptor, the LuxP&#x2013;AI-2 complex then interacts with LuxQ phosphokinase in the membrane, and finally LuxR receptor protein regulates the production of bioluminescence (<xref ref-type="bibr" rid="ref46">Roy et al., 2011</xref>). Therefore, <italic>V. harveyi</italic> is often used as a test species for laboratory AI-2 QS inhibitors (QSIs) research (<xref ref-type="bibr" rid="ref33">Lowery et al., 2008</xref>; <xref ref-type="bibr" rid="ref13">Collins et al., 2015</xref>). Research found &#x003E;40 Gram-positive and Gram-negative bacterial species can communicate using AI-2 as a signaling molecule (<xref ref-type="bibr" rid="ref35">Mok et al., 2003</xref>). AI-2-mediated QS plays a critical role in the interaction among multiple strains, and it has also been shown that AI-2 is closely related to the formation of mixed biofilms and gene regulation among multiple strains (<xref ref-type="bibr" rid="ref46">Roy et al., 2011</xref>).</p>
<p>As a Gram-positive pathogen, <italic>S. aureus</italic> has two types of QS system. One is the autoinducing peptide signaling molecule-mediated <italic>agr</italic> system, and the other is the LuxS/AI-2 system (<xref ref-type="bibr" rid="ref47">Sifri, 2008</xref>). <italic>Staphylococcus aureus</italic> is able to produce AI-2 signaling molecule, which is regulated by the <italic>luxS</italic> gene. However, no potential AI-2 receptor (such as the LuxPQ receptor of <italic>Vibrio harveyi</italic> or the LsrABC transporter of <italic>Salmonella enterica</italic> serovar Typhimurium) has been found by searching for established AI-2 receptors in <italic>S. aureus</italic> genomes (<xref ref-type="bibr" rid="ref63">Zhao et al., 2010</xref>). The LuxS/AI-2 system can negatively regulate the formation of <italic>S. aureus</italic> biofilms (<xref ref-type="bibr" rid="ref34">Ma et al., 2017</xref>), and loss of the <italic>luxS</italic> gene leads to a decrease in susceptibility to cell wall synthesis inhibitor antibiotics (<xref ref-type="bibr" rid="ref54">Wang et al., 2019</xref>). Because of the dual function of LuxS and the absence of genomic evidence of established AI-2 receptors, the AI-2 QS function in <italic>S. aureus</italic> needs further study (<xref ref-type="bibr" rid="ref63">Zhao et al., 2010</xref>).</p>
<p><italic>Pseudomonas aeruginosa</italic> lacks the <italic>luxS</italic> gene and cannot produce AI-2 signaling molecule. However, <italic>P. aeruginosa</italic> regulates the production of a variety of virulence factors and biofilms through the <italic>las</italic>, <italic>rhl</italic>, <italic>pqs</italic>, and <italic>iqs</italic> QS systems, which destroys tissues and induces inflammation, leading to impaired immune mechanisms, in an infected patient (<xref ref-type="bibr" rid="ref001">Van Delden and Iglewski, 1998</xref>). Therefore, studies in <italic>P. aeruginosa</italic> have focused on QSIs that target QS mediated by acyl-homoserine lactone (AHL) signaling molecules (<xref ref-type="bibr" rid="ref11">Chbib, 2020</xref>; <xref ref-type="bibr" rid="ref27">Jiang et al., 2020</xref>). Nevertheless, <italic>P. aeruginosa</italic> can sense the AI-2 signaling molecule produced by other bacteria, such as <italic>Escherichia coli</italic> (<xref ref-type="bibr" rid="ref46">Roy et al., 2011</xref>), <italic>Salmonella typhimurium</italic> (<xref ref-type="bibr" rid="ref46">Roy et al., 2011</xref>), <italic>Streptococcus mitis</italic> (<xref ref-type="bibr" rid="ref55">Wang et al., 2016b</xref>), and <italic>S. aureus</italic> (<xref ref-type="bibr" rid="ref26">Hotterbeekx et al., 2017</xref>), which regulates the production of virulence factors and biofilms and increases its pathogenicity (<xref ref-type="bibr" rid="ref31">Li et al., 2015</xref>; <xref ref-type="bibr" rid="ref55">Wang et al., 2016b</xref>). Recent studies have shown that C<sub>1</sub>-alkyl AI-2 analogs reduced <italic>V. harveyi</italic> QS-associated bioluminescence (<xref ref-type="bibr" rid="ref32">Lowery et al., 2009</xref>), and analogs of 4,5-dihydroxy-2,3-pentanedione (DPD), a precursor substance of AI-2 signaling molecule, like butyl and pentyl-DPD, were shown to inhibit pyocyanin production by <italic>P. aeruginosa</italic> by 50% (<xref ref-type="bibr" rid="ref22">Ganin et al., 2009</xref>). Inhibiting the AI-2 QS system using a QSI is a new strategy to treat bacterial infections caused by <italic>P. aeruginosa</italic> and <italic>S. aureus</italic>.</p>
<p>In our previous study, 14 AI-2 QSI compounds were selected through virtual screening. In this study, <italic>V. harveyi</italic> BB170 was used as a reporter strain for the preliminary screening. Compound Str7410, which had the highest AI-2 QS inhibition activity, was chosen for further research. We then co-cultured <italic>P. aeruginosa</italic> PAO1 with <italic>S. aureus</italic> ATCC 25923 to analyze the inhibitory effects of compound Str7410 on multispecies infections <italic>in vitro</italic> and <italic>in vivo</italic>. The effects of the compound on biofilm formation and of the combination of Str7410 with antibiotics on drug resistance were determined <italic>in vitro</italic>. We tested the effects of Str7410 on <italic>P. aeruginosa</italic> PAO1 virulence factor (pyocyanin and elastase) production, swarming motility, and the expression of QS-related genes in co-culture of <italic>P. aeruginosa</italic> and <italic>S. aureus</italic>. We used <italic>Caenorhabditis elegans</italic> N2 as an <italic>in vivo</italic> model to test the effects of Str7410 on survival rates on co-infection of the nematode with <italic>P. aeruginosa</italic> and <italic>S. aureus</italic>. Finally, we preliminarily evaluated the inhibitory mechanism of interspecies QS by the compound. This study provides a new strategy for the treatment of clinical multispecies infections.</p>
</sec>
<sec id="sec2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec3">
<title>Synthesis of Compound Str7410</title>
<p>All the chemical reagents used in the synthesis reactions were analytical-grade and available from commercial resources without further purification. All the reactions were monitored by analytical thin-layer chromatography (TLC) using silica gel TLC plates (GF254). Silica gel (200&#x2013;300 mesh) was used for chromatography. The <sup>1</sup>H and <sup>13</sup>C nuclear magnetic resonance (NMR) spectroscopy were recorded on a JEOLECA400 spectrometer, with TMS as an internal standard at ambient temperature. All coupling constants were reported in Hertz. Proton coupling patterns were described as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), and broad (br). High-resolution mass spectra (HRMS) were obtained by electrospray ionization (ESI) using an Agilent TOF G6230A mass spectrometer. The synthesis of compound Str7410 was shown in <xref rid="scheme1" ref-type="fig">Scheme 1</xref>. Intermediates 1, 2, and 3 were prepared by the following routes.</p>
<fig position="float" id="scheme1">
<label>Scheme 1</label>
<caption><p>Synthetic route toward the target compound Str7410. <sup>&#x0251;</sup>Reagents and conditions. <bold>(A)</bold> <italic>N</italic>-tert-butoxycarbonyl-1,2-ethylenediamine, K<sub>2</sub>CO<sub>3</sub>, MeCN, 65&#x00B0;C, and 63% yield; <bold>(B)</bold> trifluoroacetic acid, CH<sub>2</sub>Cl<sub>2</sub>, room temperature, and 100% yield; and <bold>(C)</bold> K<sub>2</sub>CO<sub>3</sub>, ethyl 2-bromoacetate, MeCN, 45&#x00B0;C, and 56% yield; <bold>(D)</bold> concentrated hydrochloric acid, 100&#x00B0;C, and 54% yield.</p></caption>
<graphic xlink:href="fmicb-13-791802-g008.tif"/>
</fig>
</sec>
<sec id="sec4">
<title>Synthesis of Tert-Butyl (2-(Heptylamino)Ethyl)Carbamate (1)</title>
<p>To a solution of <italic>N</italic>-tert-butoxycarbonyl-1,2-ethylenediamine (4.49&#x2009;g, 28.0&#x2009;mmol) in CH<sub>3</sub>CN (60&#x2009;ml) was added K<sub>2</sub>CO<sub>3</sub> (1.55&#x2009;g, 11.2&#x2009;mmol), then the mixture was heated to 65&#x00B0;C. At this temperature, 1-bromoheptane (1&#x2009;g, 5.6&#x2009;mmol) in CH<sub>3</sub>CN (10&#x2009;ml) was added dropwise to the mixture. The mixture was stirred at 80&#x00B0;C for 6&#x2009;h and cooled to room temperature. The solvent was concentrated <italic>in vacuo</italic>. The residue was dissolved in CHCl<sub>3</sub>, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <italic>in vacuo</italic>. The residue was purified by flash silica gel chromatography (1% triethylamine, petroleum ether: ethyl acetate&#x2009;=&#x2009;1: 3) to afford 1 as colorless oil (0.91&#x2009;g, 63%). <sup>1</sup>H NMR [400&#x2009;MHz, dimethylsulfoxide (DMSO)-d<sub>6</sub>] &#x03B4; 6.69 (<italic>t</italic>, <italic>J</italic>&#x2009;=&#x2009;6.8&#x2009;Hz, 1H), 2.98 (<italic>q</italic>, <italic>J</italic>&#x2009;=&#x2009;6.2&#x2009;Hz, 2H), 2.53&#x2013;2.48 (<italic>m</italic>, 2H), 2.46 (<italic>t</italic>, <italic>J</italic>&#x2009;=&#x2009;7.0&#x2009;Hz, 2H), 1.37 (<italic>s</italic>, 11H), 1.25 (<italic>s</italic>, 8H), and 0.86 (<italic>t</italic>, <italic>J</italic>&#x2009;=&#x2009;6.8&#x2009;Hz, 3H). <sup>13</sup>C NMR (101&#x2009;MHz, DMSO) &#x03B4; 156.14, 77.94, 49.52, 31.83, 30.10, 29.21, 28.75, 27.29, 22.59, and 14.46. HRMS (ESI) of C<sub>14</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub> [M&#x2009;+&#x2009;H]<sup>+</sup> calcd., 259.2381; found 259.2380.</p>
</sec>
<sec id="sec5">
<title>Synthesis of <italic>N</italic><sup>1</sup>-Heptylethane-1,2-Diamine (2)</title>
<p>To a cold (0&#x00B0;C) solution of trifluoroacetic acid (2.5&#x2009;ml) and CH<sub>2</sub>Cl<sub>2</sub> (7.5&#x2009;ml) was added tert-butyl (2-(heptylamino)ethyl)carbamate (0.5&#x2009;g, 1.9&#x2009;mmol), then the mixture was warmed to room temperature and stirred for 2&#x2009;h. The solution was concentrated <italic>in vacuo</italic> and used directly in the next step without further purification.</p>
</sec>
<sec id="sec6">
<title>Synthesis of Diethyl 2,2'-((2-((2-Ethoxy-2-Oxoethyl)(Heptyl)Amino)Ethyl)Azanediyl)Diacetate (3)</title>
<p>To a solution of <italic>N</italic><sup>1</sup>-heptylethane-1,2-diamine (0.3&#x2009;g, 1.9&#x2009;mmol) in CH<sub>3</sub>CN (40&#x2009;ml) was added K<sub>2</sub>CO<sub>3</sub> (1.05&#x2009;g, 7.6&#x2009;mmol) and ethyl 2-bromoacetate (0.98&#x2009;g, 5.9&#x2009;mmol). Then, the mixture was stirred at 45&#x00B0;C for 3&#x2009;h and cooled to room temperature. The solvent was concentrated <italic>in vacuo</italic>. The residue was dissolved in CHCl<sub>3</sub>, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <italic>in vacuo</italic>. The residue was purified by flash silica gel chromatography (1% triethylamine, CH<sub>2</sub>Cl<sub>2</sub>: CH<sub>3</sub>OH&#x2009;=&#x2009;20: 1) to afford 3 as colorless oil (0.44&#x2009;g, 56%). <sup>1</sup>H NMR (400&#x2009;MHz, DMSO-d<sub>6</sub>) &#x03B4; 4.09 (<italic>t</italic>, <italic>J</italic>&#x2009;=&#x2009;7.1&#x2009;Hz, 6H), 3.57 (<italic>s</italic>, 4H), 3.37 (<italic>s</italic>, 2H), 2.93 (<italic>d</italic>, <italic>J</italic>&#x2009;=&#x2009;5.0&#x2009;Hz, 2H), 2.89 (<italic>d</italic>, <italic>J</italic>&#x2009;=&#x2009;4.9&#x2009;Hz, 2H), 2.86&#x2013;2.81 (<italic>m</italic>, 2H), 1.50 (<italic>m</italic>, 2H), 1.27 (<italic>s</italic>, 8H), 1.21 (<italic>t</italic>, <italic>J</italic>&#x2009;=&#x2009;7.1&#x2009;Hz, 9H), and 0.87 (<italic>d</italic>, <italic>J</italic>&#x2009;=&#x2009;7.1&#x2009;Hz, 3H). <sup>13</sup>C NMR (101&#x2009;MHz, DMSO) &#x03B4; 171.47, 169.40, 60.46, 56.23, 55.06, 54.58, 52.49, 50.32, 31.64, 28.90, 26.73, 25.54, 22.53, 14.60, and 14.43. HRMS (ESI) of C<sub>21</sub>H<sub>40</sub>N<sub>2</sub>O<sub>6</sub> [M&#x2009;+&#x2009;H]<sup>+</sup> calcd., 417.2959; found 417.2960.</p>
</sec>
<sec id="sec7">
<title>Synthesis of 2,2'-((2-((Carboxymethyl)(Heptyl)Amino)Ethyl)Azanediyl)Diacetic Acid (4)</title>
<p>Diethyl 2,2'-((2-((2-ethoxy-2-oxoethyl)(heptyl)amino)ethyl)azanediyl) diacetate (0.2&#x2009;g, 0.5&#x2009;mmol) was added to concentrated hydrochloric acid (15&#x2009;ml). The mixture was heated to 100&#x00B0;C and stirred for 12&#x2009;h. Then, the residue was cooled to room temperature and concentrated <italic>in vacuo</italic>. The residue was added to concentrated hydrochloric acid (15&#x2009;ml), and the mixture was stirred at 100&#x00B0;C for 12&#x2009;h and concentrated <italic>in vacuo</italic>. The residue was recrystallized with ethanol (5&#x2009;ml) and methyl tert-butyl ether (MTBE, 45&#x2009;ml), filtered, and washed with MTBE to afford 4 as white solid (86.2&#x2009;mg, 54%). <sup>1</sup>H NMR (400&#x2009;MHz, DMSO-d<sub>6</sub>) &#x03B4; 4.23 (<italic>s</italic>, 2H), 3.63 (<italic>s</italic>, 4H), 3.37 (<italic>t</italic>, <italic>J</italic>&#x2009;=&#x2009;5.6&#x2009;Hz, 2H), 3.26&#x2013;3.19 (<italic>m</italic>, 2H), 3.16 (<italic>t</italic>, <italic>J</italic>&#x2009;=&#x2009;5.9&#x2009;Hz, 2H), 1.71&#x2013;1.59 (<italic>m</italic>, 2H), 1.26 (<italic>s</italic>, 8H), and 0.89&#x2013;0.83 (<italic>m</italic>, 3H). <sup>13</sup>C NMR (101&#x2009;MHz, DMSO) &#x03B4; 172.64, 168.12, 55.11, 54.97, 53.39, 51.70, 49.28, 31.51, 28.67, 26.34, 23.68, 22.49, and 14.44. HRMS (ESI) of C<sub>15</sub>H<sub>28</sub>N<sub>2</sub>O<sub>6</sub> [M&#x2009;+&#x2009;H]<sup>+</sup> calcd., 333.2020; found 333.2019.</p>
</sec>
<sec id="sec8">
<title>Bacterial Strains and Growth Media</title>
<p><italic>Vibrio harveyi</italic> BB170 (ATCC BAA-1117), <italic>S. aureus</italic> ATCC 25923, <italic>P. aeruginosa</italic> PAO1, and <italic>E. coli</italic> OP50 were used in this study. AB medium contained 0.3&#x2009;M NaCl, 0.05&#x2009;M MgSO<sub>4</sub>, and 2% acid-hydrolyzed casein (without vitamins), adjusted to pH 7.5 with 1&#x2009;M KOH. After autoclaving at 121&#x00B0;C, 10&#x2009;ml of 1&#x2009;M potassium phosphate buffer (K<sub>2</sub>HPO<sub>4</sub>/KH<sub>2</sub>PO<sub>4</sub>, pH 7.0), 10&#x2009;ml of 0.1&#x2009;M sterile arginine solution (L-Arg), and 20&#x2009;ml of 50% sterile glycerol were added to the medium (per 1&#x2009;L). LB medium contained 1% tryptone, 1% NaCl, and 0.5% yeast extract. TSB medium contained 1.5% tryptone, 0.5% soy peptone, and 0.5% NaCl (pH&#x2009;=&#x2009;7.2&#x2009;&#x00B1;&#x2009;0.2). PB medium contained 2% peptone, 1% K<sub>2</sub>SO<sub>4</sub>, and 0.3% MgCl<sub>2</sub>. PTSB medium contained 5% peptone, 1.7% tryptone, 0.5% NaCl, 0.25% K<sub>2</sub>HPO<sub>4</sub>, 0.25% glucose, and 0.3% soy peptone. PGS-agar plates contained 1% peptone, 0.15&#x2009;M sorbitol, 1% NaCl, 1% glucose, and 1.7% agar. Swimming solid medium contained 0.8% nutrient broth, 0.5% glucose, and 0.3% agar. Swarming solid medium contained 0.8% nutrient broth, 0.5% glucose, and 0.5% agar.</p>
<p>Test compounds were dissolved in DMSO to a stock concentration of 65&#x2009;mM. Antibiotics [tobramycin base, meropenem trihydrate (MEPM), ceftazidime, amikacin, colistin sulfate, and ciprofloxacin] were purchased from Sigma and stored at 6.4&#x2009;mg/ml at &#x2212;20&#x00B0;C.</p>
</sec>
<sec id="sec9">
<title>Half-Maximal Inhibitory Concentration of Compounds in Assay of <italic>Vibrio harveyi</italic> BB170 QS</title>
<p>The concentration of compounds that resulted in 50% maximum <italic>V. harveyi</italic> BB170 bioluminescence (the IC<sub>50</sub> value) was tested as described previously (<xref ref-type="bibr" rid="ref13">Collins et al., 2015</xref>). <italic>Vibrio harveyi</italic> BB170 was grown in AB medium (14&#x2009;h, 30&#x00B0;C) to OD<sub>600&#x2009;nm</sub>&#x2009;=&#x2009;1.5. The cells were diluted into fresh AB medium (1:2,500) and added (100&#x2009;&#x03BC;l/well) to serially diluted test compounds in AB medium (100&#x2009;&#x03BC;l/well); the final DMSO concentration was 0.5%. The plate was incubated at 30&#x00B0;C for 8&#x2009;h, and then the bioluminescence (OD<sub>460&#x2009;nm</sub>) and cell density (OD<sub>600&#x2009;nm</sub>) were measured. The values of OD<sub>460&#x2009;nm</sub> and OD<sub>600&#x2009;nm</sub> were normalized and IC<sub>50</sub> values were calculated using GraphPad Prism 5 software.</p>
</sec>
<sec id="sec10">
<title>Growth Assays</title>
<p><italic>Pseudomonas aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 were inoculated into LB medium, respectively, and cultured at 37&#x00B0;C at 150&#x2009;rpm until OD<sub>600&#x2009;nm</sub>&#x2009;=&#x2009;0.5. Then, the cultures were diluted with fresh LB medium to OD<sub>600&#x2009;nm</sub>&#x2009;=&#x2009;0.05. Next, the bacteria were cultured in the presence of compound Str7410 (80, 40, 20, 10, and 1&#x2009;&#x03BC;M), and OD<sub>600&#x2009;nm</sub> was measured at intervals of 2&#x2009;h for up to 24&#x2009;h using a spectrophotometer (UV-1800, Bio-Rad Smart Spec Plus, United States). All experiments were performed three times, independently (<xref ref-type="bibr" rid="ref55">Wang et al., 2016b</xref>).</p>
</sec>
<sec id="sec11">
<title>Biofilm Quantification Assays</title>
<p>Quantitative analysis of biofilms used crystal violet assay (<xref ref-type="bibr" rid="ref2">Armbruster et al., 2016</xref>). First, we used fresh LB medium to dilute <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 cultures in the logarithmic growth phase to OD<sub>600&#x2009;nm</sub>&#x2009;=&#x2009;0.05, and then mixed them in equal proportions in the same volume and added them to a 96-well plate (100&#x2009;&#x03BC;l/well, three parallel wells for each group). The final test compound concentrations were 80, 40, 20, 10, and 1&#x2009;&#x03BC;M. The 96-well plate was incubated at 37&#x00B0;C for 24&#x2009;h, then the bacterial culture was removed, and the plate was washed three times with phosphate-buffered saline (PBS) and dried. Next, 0.1% (w/v) crystal violet solution was added for 10&#x2009;min. After washing three times with PBS, the crystal violet-stained biofilms were air-dried. To quantify the biofilm biomass, the crystal violet was removed by adding 150&#x2009;&#x03BC;l of 33% glacial acetic acid, and OD<sub>595&#x2009;nm</sub> of the solubilized dye was determined using a Biotek multifunction microplate reader. The biofilm inhibition rate was defined as (OD<sub>595 blank</sub>&#x2009;&#x2212;&#x2009;OD<sub>595 sample</sub>)/OD<sub>595 blank</sub>&#x2009;&#x00D7;&#x2009;100%. Each crystal violet assay was run in triplicate, with a minimum of three replicates per assay.</p>
</sec>
<sec id="sec12">
<title>Determination of Susceptibility to Antibiotics</title>
<p>The determination of minimal inhibitory concentrations (MICs) was performed as described previously (<xref ref-type="bibr" rid="ref41">Peeters et al., 2009</xref>; <xref ref-type="bibr" rid="ref24">Guo et al., 2016</xref>). <italic>Pseudomonas aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 were, respectively, cultured in LB medium to OD<sub>600&#x2009;nm</sub>&#x2009;=&#x2009;0.8. <italic>Pseudomonas aeruginosa</italic> PAO1 alone or in co-culture with <italic>S. aureus</italic> ATCC 25923 (mixed in equal proportions) were diluted 1,000-fold with fresh LB medium and added to a 96-well plate. According to the broth dilution method, Antibiotics concentrations ranged from 64 to 0.125&#x2009;&#x03BC;g/ml. Finally, the plates were incubated at 37&#x00B0;C for 18&#x2009;h, and OD<sub>590&#x2009;nm</sub> was determined using a Biotek multifunction microplate reader.</p>
<p>Determination of minimum biofilm inhibitory concentrations (MBICs) of antibiotics (<xref ref-type="bibr" rid="ref53">Wang et al., 2016a</xref>). Based on the above method, 100&#x2009;&#x03BC;l of diluted bacteria was added to each well of a 96-well plate and cultured at 37&#x00B0;C for 48&#x2009;h. After removing the bacterial culture, the biofilms were washed twice using PBS. Antibiotics and fresh LB medium were added to the 96-well plate, which was incubated at 37&#x00B0;C for 24&#x2009;h. The lowest drug concentration without turbidity well is MBIC value of antibiotics.</p>
<p>For the minimum biofilm eradication concentrations (MBECs) of compound for biofilm cells (<xref ref-type="bibr" rid="ref51">Tsukatani et al., 2016</xref>, <xref ref-type="bibr" rid="ref52">2020</xref>), the 96-well plate containing 100&#x2009;&#x03BC;l diluted bacterial solution of each well was incubated at 37&#x00B0;C for 24&#x2009;h. After removing the bacterial culture, the biofilms were washed three times using PBS, then 180&#x2009;&#x03BC;l reaction solution of 2-fold serial dilutions of compound (range 1,024&#x2013;1&#x2009;&#x03BC;g/ml) in fresh LB medium added to 96-well plate. After 20&#x2009;h challenge at 37&#x00B0;C, the reaction solution were removed and washed three times with sterile PBS, then 150&#x2009;&#x03BC;l fresh LB medium added to each well of 96-well plate and incubated for a further 24&#x2009;h at 37&#x00B0;C. After removing the LB medium, the biofilms were washed three times using PBS and dried, and then 150&#x2009;&#x03BC;l 0.1% (w/v) crystal violet solution was added for 10&#x2009;min. After washing three times with PBS, adding 150&#x2009;&#x03BC;l of 33% glacial acetic acid to 96-well plate, and the OD<sub>460&#x2009;nm</sub> was measured using a Biotek multifunction microplate reader. The MBEC represents the lowest concentration of constituents for which the biofilm eradication activity was &#x003E;99%. Biofilm eradication activity (%) was determined using the following formula:</p>
<disp-formula id="E1"><mml:math id="M1"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mi mathvariant="normal">Biofilm eradication</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">activity</mml:mi><mml:mspace width="thickmathspace"/><mml:mfenced><mml:mi>&#x0025;</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">OD</mml:mi></mml:mrow><mml:mrow><mml:mn>460</mml:mn><mml:mspace width="thickmathspace"/><mml:mi mathvariant="normal">control</mml:mi></mml:mrow></mml:msub><mml:mo>&#x2212;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">OD</mml:mi></mml:mrow><mml:mrow><mml:mn>460</mml:mn><mml:mspace width="thickmathspace"/><mml:mi mathvariant="normal">blank</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>&#x2212;</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mfenced><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">OD</mml:mi></mml:mrow><mml:mrow><mml:mn>460</mml:mn><mml:mspace width="thickmathspace"/><mml:mi mathvariant="normal">sample</mml:mi></mml:mrow></mml:msub><mml:mo>&#x2212;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">OD</mml:mi></mml:mrow><mml:mrow><mml:mn>460</mml:mn><mml:mspace width="thickmathspace"/><mml:mi mathvariant="normal">blank</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>/</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mfenced><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">OD</mml:mi></mml:mrow><mml:mrow><mml:mn>460</mml:mn><mml:mspace width="thickmathspace"/><mml:mi mathvariant="normal">control</mml:mi></mml:mrow></mml:msub><mml:mo>&#x2212;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">OD</mml:mi></mml:mrow><mml:mrow><mml:mn>460</mml:mn><mml:mspace width="thickmathspace"/><mml:mi mathvariant="normal">blank</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>&#x00D7;</mml:mo><mml:mn>100</mml:mn><mml:mi>&#x0025;</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
<p>Treatment of biofilms and quantification of cells was performed as follows. Dual-species biofilms were grown in 96-well plate. The liquid medium was decanted every 2&#x2009;days leaving the attached cells at the bottom of the plate, and fresh LB medium was added (<xref ref-type="bibr" rid="ref3">Armijo et al., 2020</xref>). After 6&#x2009;days, the liquid culture was removed and the biofilms were slowly washed twice with PBS. In the test compound&#x2009;+&#x2009;antibiotic group, the test compound (1&#x2009;&#x03BC;l, 10&#x2009;&#x03BC;M final concentration), antibiotic (1&#x2009;&#x03BC;l of MEPM, 0.5&#x2009;&#x03BC;g/ml final concentration), and LB medium (98&#x2009;&#x03BC;l) were added to each well. In the test compound or antibiotic alone groups, 99&#x2009;&#x03BC;l of LB medium and 1&#x2009;&#x03BC;l of test compound or MEPM were added, respectively. In the antibiotic&#x2009;+&#x2009;sonication group, bacteria in the biofilm were detached by sonication (40&#x2009;kHz, 300&#x2009;W, and 5&#x2009;min) before adding 99&#x2009;&#x03BC;l of LB medium and 1&#x2009;&#x03BC;l of MEPM. In the control group, 100&#x2009;&#x03BC;l of LB medium was added. After incubation for 3.5&#x2009;h, biofilm cells were detached by sonication (40&#x2009;kHz, 300&#x2009;W, and 5&#x2009;min) and the number of colony-forming units was determined by plating the resulting suspension (<xref ref-type="bibr" rid="ref9">Brackman et al., 2011</xref>; <xref ref-type="bibr" rid="ref24">Guo et al., 2016</xref>).</p>
</sec>
<sec id="sec13">
<title><italic>Caenorhabditis elegans</italic> Survival Assay</title>
<p><italic>Pseudomonas aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 were cultured to OD<sub>600&#x2009;nm</sub>&#x2009;=&#x2009;2.0 at 37&#x00B0;C in TSB medium, respectively. Then, after mixing in equal proportions, 20&#x2009;&#x03BC;l of culture were spread on PGS-agar plates containing antibiotic or test compound. The plates were placed in an incubator at 37&#x00B0;C and cultured for 18&#x2009;h to allow the formation of a bacterial lawn. Then, 50 synchronized nematodes (L4 stage of wild-type <italic>C. elegans</italic> N2) were selected and placed on a plate. The plates were incubated at 20&#x00B0;C and the number of living and dead nematodes was counted every 24&#x2009;h using a stereomicroscope. A nematode was defined as dead when it no longer responded to touch. Any nematodes that died as a result of getting stuck to the wall of the plate were excluded from the analysis. Survival curves were drawn for analysis (<xref ref-type="bibr" rid="ref43">Rajkumari et al., 2018</xref>).</p>
</sec>
<sec id="sec14">
<title>Virulence Factor Quantification</title>
<p>Pyocyanin was quantified as follows: <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 were, respectively, cultured in LB medium at 37&#x00B0;C, 150&#x2009;rpm, to the logarithmic growth phase. After mixing in equal proportions, the culture was diluted tenfold with fresh PB medium. Bacterial cultures (5&#x2009;ml) with and without the test compound (40, 20, and 10&#x2009;&#x03BC;M) were incubated at 37&#x00B0;C and 150&#x2009;rpm for 16&#x2009;h. To extract pyocyanin, the culture was centrifuged at 1,665&#x2009;&#x00D7;&#x2009;<italic>g</italic> for 10&#x2009;min, and the supernatant was collected and extracted with 3&#x2009;ml of chloroform. Then, 1&#x2009;ml of 0.2&#x2009;M HCl was mixed with the chloroform layer, and the upper (aqueous) phase was collected by centrifugation at 1,665&#x2009;&#x00D7;&#x2009;<italic>g</italic> for 10&#x2009;min. The absorbance was measured at 520&#x2009;nm (<xref ref-type="bibr" rid="ref20">Essar et al., 1990</xref>). The inhibition rate of pyocyanin production was calculated as (OD<sub>520 blank</sub>&#x2009;&#x2212;&#x2009;OD<sub>520 sample</sub>)/OD<sub>520 blank</sub>&#x2009;&#x00D7;&#x2009;100%.</p>
<p>Elastase was determined using the Elastin-Congo red assay with modifications, and the final absorbance was read at 495&#x2009;nm (<xref ref-type="bibr" rid="ref40">Pearson et al., 1997</xref>). <italic>Pseudomonas aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 were, respectively, cultured in PTSB medium at 37&#x00B0;C and 150&#x2009;rpm to the logarithmic growth phase. After mixing in equal proportions, co-cultures were divided into the experimental group and the control group, and then incubated at 37&#x00B0;C and 150&#x2009;rpm for 18&#x2009;h. Then, the cultures were centrifuged at 9,590&#x2009;&#x00D7;&#x2009;<italic>g</italic> for 5&#x2009;min and the supernatant was collected. The bacteria were filtered through a 0.22-&#x03BC;m pore-size filter. Then, 200&#x2009;&#x03BC;l of the filtrate was added to 1&#x2009;ml of Elastin-Congo red reaction solution [20&#x2009;mg/ml Congo red, 0.1&#x2009;M Tris&#x2013;HCl (pH 7.2), and 1&#x2009;mM CaCl<sub>2</sub>], and the mixture was shaken for 18&#x2009;h at 37&#x00B0;C. Stop-reaction solution (ethylenediaminetetraacetic acid, 0.1&#x2009;ml, and 0.12&#x2009;M) was added and the mixture was incubated on ice for 5&#x2009;min, and then centrifuged at 9,590&#x2009;&#x00D7;&#x2009;<italic>g</italic> for 10&#x2009;min. The supernatant was collected and OD<sub>495nm</sub> was determined.</p>
</sec>
<sec id="sec15">
<title>Swarming Motility Assay</title>
<p><italic>Pseudomonas aeruginosa</italic> PAO1 was shaken in LB medium at 37&#x00B0;C until OD<sub>600&#x2009;nm</sub>&#x2009;=&#x2009;1.0. Bacterial culture (1&#x2009;&#x03BC;l) was inoculated into the center of cooled swimming solid medium and further cultured at 30&#x00B0;C for 16&#x2009;h. <italic>Staphylococcus aureus</italic> ATCC 25923 was shaken at 37&#x00B0;C in LB medium to OD<sub>600&#x2009;nm</sub>&#x2009;=&#x2009;0.5. The culture was centrifuged at 9,590&#x2009;&#x00D7;&#x2009;<italic>g</italic> for 5&#x2009;min, and the supernatant was filtered (0.22-&#x03BC;m pore-size). The filtered supernatant was added to thawed swarming solid medium at a ratio of 1:10, mixed, poured into a plate, and left to stand for 8&#x2009;h to dry. Finally, colonies were picked from the <italic>P. aeruginosa</italic> PAO1 swimming solid medium, added to the center of the swarming solid plate, and cultured at 30&#x00B0;C for 16&#x2009;h (<xref ref-type="bibr" rid="ref50">Tremblay and Deziel, 2008</xref>; <xref ref-type="bibr" rid="ref38">Pallett et al., 2019</xref>).</p>
</sec>
<sec id="sec16">
<title>Quantitative Reverse Transcriptase PCR</title>
<p><italic>Pseudomonas aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 cultured overnight for 16&#x2009;h were diluted with fresh LB medium to OD<sub>600&#x2009;nm</sub>&#x2009;=&#x2009;0.05. After mixing in equal proportions, they were divided into a control group and an experimental group (with test compound added) and grown at 37&#x00B0;C and 150&#x2009;rpm for 10&#x2009;h. <italic>Pseudomonas aeruginosa</italic> PAO1 was also grown in monoculture. After centrifugation (9,590&#x2009;&#x00D7;&#x2009;<italic>g</italic>, 5&#x2009;min) to retain the bacterial cells, a one-step cDNA kit was used [5&#x00D7; All-In-One RT MasterMix (With Excellent Lysis Kit, abm, Canada) for cDNA Extraction]; the DNA was stored at &#x2212;20&#x00B0;C.</p>
<p>Quantitative reverse transcriptase PCR (qRT-PCR) was performed with a Roche LightCycler&#x00AE; 480 instrument and EvaGreen 2&#x00D7; qPCR MasterMix. The 20-&#x03BC;l reaction system contained 0.6&#x2009;&#x03BC;l each of forward and reverse primers, 1&#x2009;&#x03BC;l template cDNA, 10&#x2009;&#x03BC;l EvaGreen 2&#x00D7; qPCR MasterMix, and 7.8&#x2009;&#x03BC;l nuclease-free H<sub>2</sub>O. The primer sets used for these analyses are listed in <xref rid="tab1" ref-type="table">Table 1</xref>. A no-template control was included during each qPCR experiment. The thermal cycling program started with 95&#x00B0;C for 10&#x2009;min, followed by 40&#x2009;cycles of 95&#x00B0;C for 15&#x2009;s and 60&#x00B0;C for 1&#x2009;min. After qPCR amplification, the comparative threshold method (&#x0394;&#x0394;Ct analysis) was applied to evaluate relative changes in gene expression. The experiment used GraphPad Prism 8 software for mapping (<xref ref-type="bibr" rid="ref14">Conway et al., 2012</xref>). &#x0394;&#x0394;Ct&#x2009;=&#x2009;&#x0394;&#x0394;Ct, <sub>sample</sub> &#x2013; &#x0394;&#x0394;Ct, <sub>reference</sub>.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption><p>Primers used in this study.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Gene</th>
<th align="left" valign="top">Sequence (5'&#x2013;3')</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top"><italic>lasI</italic></td>
<td align="left" valign="top">Forward: CAGGTTTCCGGTTCGTGG<break/>Reverse: TTCCTTGCCGTGCAGAAG</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lasR</italic></td>
<td align="left" valign="top">Forward: TCTACCAGACGCGAAAGCAG<break/>Reverse: GTTTGCTGACCGGATGTTCG</td>
</tr>
<tr>
<td align="left" valign="top"><italic>rhlI</italic></td>
<td align="left" valign="top">Forward: GTTCGACCATCCGCAAAC<break/>Reverse: ACGTCCTTGAGCAGGTAG</td>
</tr>
<tr>
<td align="left" valign="top"><italic>rhlR</italic></td>
<td align="left" valign="top">Forward: GACCAGCAGAACATCTCC<break/>Reverse: CTGGGTCAGCAACTCGAT</td>
</tr>
<tr>
<td align="left" valign="top"><italic>pqsH</italic></td>
<td align="left" valign="top">Forward: GAGACGCTGATCCTGTTC<break/>Reverse: CGATTCCCACTGACCAAG</td>
</tr>
<tr>
<td align="left" valign="top"><italic>pqsR</italic></td>
<td align="left" valign="top">Forward: TTGATCGTCGCCAGGCTATC<break/>Reverse: TCGTTCTGCGATACGGTGAG</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lasB</italic></td>
<td align="left" valign="top">Forward: AACCGTGCGTTCTACCTGTT<break/>Reverse: CGGTCCAGTAGTAGCGGTTG</td>
</tr>
<tr>
<td align="left" valign="top"><italic>phzH</italic></td>
<td align="left" valign="top">Forward: TGCGCGAGTTCAGCCACCTG<break/>Reverse: TCCGGGACATAGTCGGCGCA</td>
</tr>
<tr>
<td align="left" valign="top"><italic>rpsL</italic></td>
<td align="left" valign="top">Forward: TGTGCTCTTGCAGGTTGTGA<break/>Reverse: TCGGCACTGCGTAAGGTATG</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec17">
<title>Statistical Analysis</title>
<p>All assays were performed with three replicates and the values obtained are expressed as the mean&#x2009;&#x00B1;&#x2009;SD. Differences in data were compared with the untreated control at each time-point and considered significant when <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 (<sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.001) by one-way ANOVA with <italic>t</italic>-tests using GraphPad Prism 8 software.</p>
</sec>
</sec>
<sec id="sec18" sec-type="results">
<title>Results</title>
<sec id="sec19">
<title>Synthesis of Str7410</title>
<p>Synthesis of compound Str7410 was accomplished in four steps from the commercially-available 1-bromoheptane (<xref rid="scheme1" ref-type="fig">Scheme 1</xref>). Single substitution of <italic>N</italic>-tert-butoxycarbonyl-1,2-ethylenediamine with 1-bromoheptane generated intermediate 1. Removal of the Boc amino-protecting group followed by reaction with ethyl 2-bromoacetate afforded intermediate 3. Acidic hydrolysis twice afforded the desired compound Str7410.</p>
</sec>
<sec id="sec20">
<title>Effect of Compound Str7410 on <italic>Vibrio harveyi</italic> AI-2 QS</title>
<p>We used <italic>V. harveyi</italic> BB170 (a <italic>luxN</italic> mutant) as a reporter strain to evaluate the AI-2 QS inhibitory activity of test compounds. The IC<sub>50</sub> values of compounds were tested in terms of <italic>V. harveyi</italic> BB170 bioluminescence. Bromo-furanone C56 (<xref ref-type="bibr" rid="ref62">Zang et al., 2009</xref>) was used as the positive control. As shown in <xref rid="tab2" ref-type="table">Table 2</xref>, Str7410 had the best inhibitory effect on AI-2 QS of <italic>V. harveyi</italic> BB170 (IC<sub>50</sub>&#x2009;=&#x2009;0.3724&#x2009;&#x00B1;&#x2009;0.1091&#x2009;&#x03BC;M). Based on this, compound Str7410 was selected for further research.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption><p>Anti-<italic>Vibrio harveyi</italic> BB170 autoinducer-2 (AI-2) quorum sensing (QS) activities of test compounds and its structure.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Number</th>
<th align="center" valign="top">Structure</th>
<th align="center" valign="top">IC<sub>50</sub> (&#x03BC;M)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">C56</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0001.tif"/></td>
<td align="center" valign="middle">4.1&#x2009;&#x00B1;&#x2009;1.2</td>
</tr>
<tr>
<td align="left" valign="middle">Str6793</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0002.tif"/></td>
<td align="center" valign="middle">30.1&#x2009;&#x00B1;&#x2009;4.5</td>
</tr>
<tr>
<td align="left" valign="middle">Str7410</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0003.tif"/></td>
<td align="center" valign="middle">0.4&#x2009;&#x00B1;&#x2009;0.1</td>
</tr>
<tr>
<td align="left" valign="middle">Str7369</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0004.tif"/></td>
<td align="center" valign="middle">1.8&#x2009;&#x00B1;&#x2009;1.1</td>
</tr>
<tr>
<td align="left" valign="middle">Str629</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0005.tif"/></td>
<td align="center" valign="middle">29.4&#x2009;&#x00B1;&#x2009;8.8</td>
</tr>
<tr>
<td align="left" valign="middle">Str811</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0006.tif"/></td>
<td align="center" valign="middle">11.5&#x2009;&#x00B1;&#x2009;5.5</td>
</tr>
<tr>
<td align="left" valign="middle">Str1107</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0007.tif"/></td>
<td align="center" valign="middle">141.8&#x2009;&#x00B1;&#x2009;23.5</td>
</tr>
<tr>
<td align="left" valign="middle">Str120</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0008.tif"/></td>
<td align="center" valign="middle">1.8&#x2009;&#x00B1;&#x2009;1.1</td>
</tr>
<tr>
<td align="left" valign="middle">StrOMe-165-10</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0009.tif"/></td>
<td align="center" valign="middle">64.4&#x2009;&#x00B1;&#x2009;9.6</td>
</tr>
<tr>
<td align="left" valign="middle">Str3533</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0010.tif"/></td>
<td align="center" valign="middle">30.1&#x2009;&#x00B1;&#x2009;4.5</td>
</tr>
<tr>
<td align="left" valign="middle">Str5036</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0011.tif"/></td>
<td align="center" valign="middle">41.0&#x2009;&#x00B1;&#x2009;22.9</td>
</tr>
<tr>
<td align="left" valign="middle">Str5015</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0012.tif"/></td>
<td align="center" valign="middle">60.9&#x2009;&#x00B1;&#x2009;8.5</td>
</tr>
<tr>
<td align="left" valign="middle">StrOMe-780-1</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0013.tif"/></td>
<td align="center" valign="middle">64.5&#x2009;&#x00B1;&#x2009;10.2</td>
</tr>
<tr>
<td align="left" valign="middle">Str5722</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0014.tif"/></td>
<td align="center" valign="middle">1162.0&#x2009;&#x00B1;&#x2009;476.1</td>
</tr>
<tr>
<td align="left" valign="middle">Str6467</td>
<td align="center" valign="middle"><inline-graphic xlink:href="fmicb-13-791802-igr0015.tif"/></td>
<td align="center" valign="middle">92.1&#x2009;&#x00B1;&#x2009;30.9</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Values are presented as the mean&#x2009;&#x00B1;&#x2009;SD, <italic>n</italic>&#x2009;=&#x2009;3.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec21">
<title>Effect of Compound Str7410 on Bacterial Growth</title>
<p>The main difference between QSIs and antibiotics is that QSIs inhibit the production of virulence factors without killing pathogenic bacteria, so that the bacteria do not develop drug-resistance mutations (<xref ref-type="bibr" rid="ref1">Allen et al., 2014</xref>). Therefore, we analyzed the effect of the putative QSI compound Str7410 on the growth of <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923. As <xref rid="fig1" ref-type="fig">Figure 1</xref> shows, compound Str7410 affected the growth of neither bacterium.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption><p>Effect of compound Str7410 (1&#x2013;80&#x2009;&#x03BC;M) on the growth of <italic>Pseudomonas aeruginosa</italic> PAO1 and <italic>Staphylococcus aureus</italic> ATCC 25923. <bold>(A)</bold> <italic>Pseudomonas aeruginosa</italic> PAO1 growth curves. <bold>(B)</bold> <italic>Staphylococcus aureus</italic> ATCC 25923 growth curves. Values are presented as the mean&#x2009;&#x00B1;&#x2009;SD (<italic>n</italic>&#x2009;=&#x2009;3).</p></caption>
<graphic xlink:href="fmicb-13-791802-g001.tif"/>
</fig>
</sec>
<sec id="sec22">
<title>Effect of Compound Str7410 on Biofilm Formation</title>
<p>Bacterial resistance to antibiotics is related to the formation of biofilms (<xref ref-type="bibr" rid="ref28">Kalia, 2013</xref>). We used the crystal violet assay to evaluate the effect of compound Str7410 on formation of biofilms by <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 mixed in equal proportion. As shown in <xref rid="fig2" ref-type="fig">Figure 2</xref>, significantly more biofilm was formed by the mixture of species than by either species alone. When compound Str7410 was added to the co-culture, the formation of biofilm was significantly reduced [range 9.75% (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05)&#x2013;48.40% (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001)]. The inhibitory effect of compound Str7410 was concentration-dependent. When the concentration of Str7410 was 40&#x2009;&#x03BC;M, the inhibition rate of biofilm formation was 40.58% (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption><p>Crystal violet assay of biofilm formation by <italic>Pseudomonas aeruginosa</italic> PAO1 and <italic>Staphylococcus aureus</italic> ATCC 25923 alone and in co-culture after 24&#x2009;h, and the inhibitory effect of compound Str7410 on biofilm formation by the mixed culture. Values are the mean&#x2009;&#x00B1;&#x2009;SD (<italic>n</italic>&#x2009;=&#x2009;3). Differences in data were compared with the untreated control at each time-point and considered significant when <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 (<sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.001) by one-way ANOVA with <italic>t</italic>-tests.</p></caption>
<graphic xlink:href="fmicb-13-791802-g002.tif"/>
</fig>
</sec>
<sec id="sec23">
<title>Effect of Compound Str7410 on the Antibiotic Susceptibility of Biofilm Cells</title>
<p>First, the MIC and MBIC values of antibiotics for single and mixed bacteria were determined when <italic>P. aeruginosa</italic> PAO1 was cultured alone or in co-culture with <italic>S. aureus</italic> ATCC 25923. As shown in <xref rid="tab3" ref-type="table">Table 3</xref>, compared with planktonic cells, biofilm cells showed significantly increased resistance to antibiotics. The MBIC values of MEPM against biofilm cells increased 32 and 16-fold, respectively, compared with the MIC values for planktonic cells, when <italic>P. aeruginosa</italic> PAO1 was cultured alone and co-cultured with <italic>S. aureus</italic> ATCC 25923. Moreover, planktonic cells or biofilm cells from co-cultures of <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 showed significantly increased resistances to some antibiotics (ceftazidime, colistin sulfate, ciprofloxacin, and MEPM) compared with that of <italic>P. aeruginosa</italic> PAO1 monoculture. These data indicate that cultures of multiple bacterial species and the formation of biofilms can increase resistance to antibiotics. We also evaluated the MBEC of the compound Str7410 against the formed biofilm. As shown in <xref ref-type="supplementary-material" rid="SM2">Supplementary Table S1</xref>, the compound Str7410 had no eradication effect on the formed biofilm.</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption><p>Minimal inhibitory concentration (MIC) and minimum biofilm inhibitory concentration (MBIC) of antibiotics toward planktonic and biofilm cells of <italic>Pseudomonas aeruginosa</italic> PAO1 alone or in co-culture with <italic>Staphylococcus aureus</italic> ATCC 25923.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle" rowspan="2">Antibiotic</th>
<th align="center" valign="middle" colspan="2">PAO1</th>
<th align="center" valign="middle" colspan="2">Mixed species</th>
</tr>
<tr>
<th align="center" valign="middle">Planktonic cells MIC (&#x03BC;g/ml)</th>
<th align="center" valign="middle">Biofilm cells MBIC (&#x03BC;g/ml)</th>
<th align="center" valign="middle">Planktonic cells MIC (&#x03BC;g/ml)</th>
<th align="center" valign="middle">Biofilm cells MBIC (&#x03BC;g/ml)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Tobramycin base</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">8</td>
</tr>
<tr>
<td align="left" valign="top">Ceftazidime</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">8</td>
</tr>
<tr>
<td align="left" valign="top">Amikacin</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">16</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">16</td>
</tr>
<tr>
<td align="left" valign="top">Colistin sulfate</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">64</td>
<td align="center" valign="top">&#x003E;64</td>
<td align="center" valign="top">&#x003E;64</td>
</tr>
<tr>
<td align="left" valign="top">Ciprofloxacin</td>
<td align="center" valign="top">0.08</td>
<td align="center" valign="top">0.25</td>
<td align="center" valign="top">0.25</td>
<td align="center" valign="top">0.5</td>
</tr>
<tr>
<td align="left" valign="top">Meropenem trihydrate</td>
<td align="center" valign="top">0.25</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">0.5</td>
<td align="center" valign="top">8</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Data were obtained from three replicate experiments, <italic>n</italic>&#x2009;=&#x2009;3.</p>
</table-wrap-foot>
</table-wrap>
<p>Next, we evaluated the effects of compound Str7410 on the susceptibility of mixed-species biofilms to antibiotics. We tested the inhibitory effects of MEPM and compound Str7410 alone, and MEPM combined with compound Str7410. MEPM in combination with sonication was used as a reference treatment. As <xref rid="fig3" ref-type="fig">Figure 3</xref> shows, compound Str7410 when applied alone had no inhibitory effect on biofilms of mixed <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 cells. Treatment with MEPM alone and MPEM combined with sonication significantly decreased the number of biofilm cells (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 and <italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, respectively). The combination of MEPM with Str7410 also had a significant inhibitory effect on biofilm cells (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01). Notably, compound Str7410 increased the inhibitory effect of MEPM toward biofilm cells (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05), and the level of inhibition by Str7410&#x2009;+&#x2009;MEPM was greater than that by MEPM&#x2009;+&#x2009;sonication.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption><p>Effect of compound Str7410 on the number of cells [determined as log colony-forming units (CFU)] in biofilms formed from mixed <italic>Pseudomonas aeruginosa</italic> PAO1 and <italic>Staphylococcus aureus</italic> ATCC 25923 cells. Treatments: Str7410 (10&#x2009;&#x03BC;M) alone, meropenem trihydrate (MEPM, 0.5&#x2009;&#x03BC;g/ml) alone, and MEPM combined with sonication or Str7410. Values are presented as the mean&#x2009;&#x00B1;&#x2009;SD (<italic>n</italic>&#x2009;=&#x2009;3). Differences in data were compared with the untreated control at each time-point and considered significant when <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 (<sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, and <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01) by one-way ANOVA with <italic>t</italic>-tests.</p></caption>
<graphic xlink:href="fmicb-13-791802-g003.tif"/>
</fig>
</sec>
<sec id="sec24">
<title>Effect of Compound Str7410 on Survival of Infected <italic>Caenorhabditis elegans</italic></title>
<p>We used wild-type <italic>C. elegans</italic> N2 as a model to evaluate the effect of compound Str7410 on survival rates following co-infection with <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 <italic>in vivo</italic>.</p>
<p>After 240&#x2009;h of incubation, the survival rate of nematodes decreased by 2.55% for <italic>C. elegans</italic> co-infected with <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 compared with that of nematodes infected with <italic>P. aeruginosa</italic> PAO1 alone (<xref rid="fig4" ref-type="fig">Figure 4</xref>). This indicates that the pathogenicity caused by multispecies infection was greater than that by a single bacterial species.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption><p>Effect of treatment with compound Str7410 (40&#x2009;&#x03BC;M) and the antibiotic MEPM (0.5&#x2009;&#x03BC;g/ml) alone or combination on survival of <italic>Caenorhabditis elegans</italic> N2 co-infected with <italic>Pseudomonas aeruginosa</italic> PAO1 and <italic>Staphylococcus aureus</italic> ATCC 25923. <italic>Escherichia coli</italic> OP50 was used as a negative control. Values are presented as the mean&#x2009;&#x00B1;&#x2009;SD (<italic>n</italic>&#x2009;=&#x2009;3).</p></caption>
<graphic xlink:href="fmicb-13-791802-g004.tif"/>
</fig>
<p>Compared with the positive control group co-infected by <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923, the survival rate of the infected group treated with compound Str7410 (40&#x2009;&#x03BC;M) increased by 12.67% (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05), and the survival rate of the infected group treated with MEPM (0.5&#x2009;&#x03BC;g/ml) increased by 14.67% (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001). Furthermore, the survival rate of the group treated with the combination of Str7410 and MEPM increased by 12.67% (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) and 10.67% (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) compared with the Str7410-alone and MEPM-alone treatments, respectively (<xref rid="fig4" ref-type="fig">Figure 4</xref>). Although compound Str7410 inhibited the growth of neither <italic>P. aeruginosa</italic> PAO1 nor <italic>S. aureus</italic> ATCC 25923 (e.g., <xref rid="fig1" ref-type="fig">Figure 1</xref>), it decreased the pathogenicity of these bacteria by inhibiting interspecific QS. In addition, the combination of compound Str7410 with MEPM increased the therapeutic effect of MEPM.</p>
</sec>
<sec id="sec25">
<title>Effect of Compound Str7410 on Virulence Factors of <italic>Pseudomonas aeruginosa</italic> PAO1</title>
<p>The effect of Str7410 on virulence factors of <italic>P. aeruginosa</italic> PAO1 in multispecies infection was investigated. We quantitatively analyzed production of the virulence factors pyocyanin and elastase by <italic>P. aeruginosa</italic> PAO1 when this strain was cultured alone or co-cultured with <italic>S. aureus</italic> ATCC 25923. As <xref rid="fig5" ref-type="fig">Figure 5</xref> shows, the production of pyocyanin and elastase was significantly increased (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001 and <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, respectively) when <italic>P. aeruginosa</italic> PAO1 was co-cultured with <italic>S. aureus</italic> ATCC 25923 compared with <italic>P. aeruginosa</italic> PAO1 monoculture. However, treatment with Str7410 significantly reduced the production of pyocyanin and elastase in co-cultures compared with the untreated controls; this effect of Str7410 was concentration dependent. When the concentration of Str7410 was 40&#x2009;&#x03BC;M, the inhibition of production of pyocyanin and elastase was 22.07% (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01) and 24.85% (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05), respectively, compared with no treatment with Str7410.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption><p>Production of virulence factors by <italic>Pseudomonas aeruginosa</italic> PAO1 in monoculture or co-culture with <italic>Staphylococcus aureus</italic> ATCC 25923, and the inhibitory effect of compound Str7410 on virulence factor production in co-culture. <bold>(A)</bold> Pyocyanin; <bold>(B)</bold> Elastase. Values are presented as mean&#x2009;&#x00B1;&#x2009;SD (<italic>n</italic>&#x2009;=&#x2009;3). Differences in data were compared with the untreated control at each time-point and considered significant when <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 (<sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.001) by one-way ANOVA with <italic>t</italic>-tests.</p></caption>
<graphic xlink:href="fmicb-13-791802-g005.tif"/>
</fig>
</sec>
<sec id="sec26">
<title>Effect of Compound Str7410 on Swarming Motility of <italic>Pseudomonas aeruginosa</italic> PAO1</title>
<p>Bacterial motility is important for pathogenicity and antibiotic resistance. Swarming motility, an important virulence factor of <italic>P. aeruginosa</italic>, is mainly regulated by QS-related genes, such as <italic>lasB</italic> and <italic>pvdQ</italic> (<xref ref-type="bibr" rid="ref50">Tremblay and Deziel, 2008</xref>). Furthermore, <italic>S. aureus</italic> culture supernatant can promote the swarming motility of <italic>P. aeruginosa</italic> PAO1 under normoxia (<xref ref-type="bibr" rid="ref38">Pallett et al., 2019</xref>). Similarly, in this study, culture supernatant of <italic>S. aureus</italic> ATCC 25923 promoted the swarming motility of <italic>P. aeruginosa</italic> PAO1 (<xref rid="fig6" ref-type="fig">Figures 6A,B</xref>). However, when compound Str7410 was added, the swarming motility was significantly inhibited (<xref rid="fig6" ref-type="fig">Figures 6B,C</xref>).</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption><p>Effect of compound Str7410 on swarming motility of <italic>Pseudomonas aeruginosa</italic> PAO1. <bold>(A)</bold> Negative control (<italic>P. aeruginosa</italic> PAO1 alone). <bold>(B)</bold> Blank control (<italic>P. aeruginosa</italic> PAO1 with supernatant of <italic>Staphylococcus aureus</italic> ATCC 25923 culture). <bold>(C)</bold> Treatment group (<italic>P. aeruginosa</italic> PAO1 treated with supernatant of <italic>S. aureus</italic> ATCC 25923 culture and 10&#x2009;&#x03BC;M Str7410).</p></caption>
<graphic xlink:href="fmicb-13-791802-g006.tif"/>
</fig>
</sec>
<sec id="sec27">
<title>Expression of QS-Related Genes in <italic>Pseudomonas aeruginosa</italic> PAO1 in Mixed Culture</title>
<p>From the data above, we found that <italic>S. aureus</italic> ATCC 25923 can increase the production of virulence factors and the swarming motility of <italic>P. aeruginosa</italic> PAO1 on co-culture of strains PAO1 and ATCC 25923. Compound Str7410 significantly inhibited this. These findings indicate that in multispecies infections, bacteria can enhance pathogenicity through their interactions, potentially <italic>via</italic> AI-2 QS systems. Therefore, we quantified the relative expression of QS-related genes of <italic>P. aeruginosa</italic> PAO1 in co-culture of <italic>P. aeruginosa</italic> PAO1 with <italic>S. aureus</italic> ATCC 25923. As shown in <xref rid="fig7" ref-type="fig">Figure 7</xref>, the expression of PAO1 QS-related genes (<italic>lasI</italic>, <italic>lasR</italic>, <italic>rhlI</italic>, <italic>rhlR</italic>, <italic>pqsH</italic>, and <italic>pqsR</italic>) and virulence factor-related genes (elastase, <italic>lasB</italic>; pyocyanin, and <italic>phzH</italic>) was significantly upregulated in the co-culture group compared with that in <italic>P. aeruginosa</italic> PAO1 monoculture. When Str7410 (40&#x2009;&#x03BC;M) was added, the expression of all the strain PAO1 QS genes was significantly downregulated in co-culture compared with that in the absence of Str7410.</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption><p>Expression on quorum sensing (QS) and virulence factor-related genes of <italic>Pseudomonas aeruginosa</italic> PAO1 when strain PAO1 was co-cultured with <italic>Staphylococcus aureus</italic> ATCC 25923 compared with PAO1 monoculture, and the effect of compound Str7410 (40&#x2009;&#x03BC;M) on the expression of PAO1 QS and virulence factor-related genes in co-culture. Values are presented as the mean&#x2009;&#x00B1;&#x2009;SD (<italic>n</italic>&#x2009;=&#x2009;3).</p></caption>
<graphic xlink:href="fmicb-13-791802-g007.tif"/>
</fig>
</sec>
</sec>
<sec id="sec28" sec-type="discussions">
<title>Discussion</title>
<p>Bacterial infections, such as chronic wound infections and lung infections in patients with <italic>CF</italic>, are often caused by infection with multiple bacterial species (<xref ref-type="bibr" rid="ref16">DeLeon et al., 2014</xref>; <xref ref-type="bibr" rid="ref36">Nguyen and Oglesby-Sherrouse, 2016</xref>). <italic>Pseudomonas aeruginosa</italic> is a major opportunistic pathogen in hospitals, and nearly 80% of 18-year-old <italic>CF</italic> patients suffer chronic colonization and infection by <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="ref19">Duan et al., 2003</xref>). <italic>Staphylococcus aureus</italic> is another main bacterium in <italic>CF</italic> and chronic wounds. <italic>Staphylococcus aureus</italic> can interact with <italic>P. aeruginosa</italic> to promote the development of disease (<xref ref-type="bibr" rid="ref5">Baldan et al., 2014</xref>). Studies demonstrated that <italic>P. aeruginosa</italic> and <italic>S. aureus</italic> compete with each other when co-cultured <italic>in vitro</italic>, and <italic>P. aeruginosa</italic> can produce 4-hydroxy-2-heptylquinoline-<italic>N</italic>-oxide (HQNO) through the <italic>pqs</italic> system to inhibit the aerobic respiration of <italic>S. aureus</italic> (<xref ref-type="bibr" rid="ref56">Williams and Camara, 2009</xref>). In addition, virulence factors produced by <italic>P. aeruginosa</italic>, such as pyocyanin, have a significant inhibitory effect on the aerobic respiration and growth of <italic>S. aureus</italic> (<xref ref-type="bibr" rid="ref20">Essar et al., 1990</xref>). However, although <italic>P. aeruginosa</italic> inhibits the growth of <italic>S. aureus</italic> in the planktonic state, a mixture of the two strains coordinates in the formation of biofilms and resistance to antibiotics. <italic>Staphylococcus aureus</italic> can avoid inhibition by <italic>P. aeruginosa</italic> by forming small colony variants, while the extracellular polymeric substances produced by <italic>P. aeruginosa</italic> can protect <italic>S. aureus</italic> from the killing effect of antibiotics (<xref ref-type="bibr" rid="ref4">Atalla et al., 2011</xref>). Furthermore, <italic>P. aeruginosa</italic> and <italic>S. aureus</italic> co-culture promotes the production of virulence factors, which increase bacterial pathogenicity (<xref ref-type="bibr" rid="ref15">Dalton et al., 2011</xref>; <xref ref-type="bibr" rid="ref37">Orazi and O&#x2019;Toole, 2017</xref>). Studies have indicated that QS mediated by AI-2 signaling molecules, a general communication system between bacteria, plays an important role in bacterial pathogenicity and drug resistance (<xref ref-type="bibr" rid="ref19">Duan et al., 2003</xref>). In infectious disease, multiple species can coordinate with each other <italic>via</italic> QS, promoting bacterial pathogenicity and drug resistance. <italic>Pseudomonas aeruginosa</italic> can sense AI-2 signaling molecules produced by <italic>Streptococcus mitis</italic>, <italic>Staphylococcus aureus</italic>, and so on, leading to increased production of its own virulence factors and the formation of biofilms (<xref ref-type="bibr" rid="ref19">Duan et al., 2003</xref>; <xref ref-type="bibr" rid="ref31">Li et al., 2015</xref>; <xref ref-type="bibr" rid="ref55">Wang et al., 2016b</xref>). Therefore, research into inhibitors of AI-2-mediated QS is a new strategy to target multispecies infections.</p>
<p>In previous study, we used the AI-2 signal molecule receptor LuxP as a target to screen 8,600 small molecule compounds from an in-house compound library using virtual screening techniques, and identified 14 AI-2 QSI compounds (<xref ref-type="bibr" rid="ref61">Yuan, 2019</xref>). Wild-type <italic>V. harveyi</italic> senses AHL signal molecules as well as AI-2 signal molecules. To eliminate interference from AHLs, <italic>V. harveyi</italic> strain BB170 was used as the reporter here; this strain lacks the LuxN receptor for AHLs, but contains the LuxP receptor to sense AI-2 (<xref ref-type="bibr" rid="ref44">Ren et al., 2001</xref>). As shown in <xref rid="tab2" ref-type="table">Table 2</xref>, compound Str7410 had the best inhibitory effect on AI-2 QS by <italic>V. harveyi</italic> BB170 (IC<sub>50</sub>&#x2009;=&#x2009;0.3724&#x2009;&#x00B1;&#x2009;0.1091&#x2009;&#x03BC;M). Thus, we selected compound Str7410 as the test compound to evaluate its inhibitory effect on interspecific QS when <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 were co-cultured.</p>
<p>Because of abuse of antibiotics, bacterial drug resistance is increasing. In multibacterial infections, pathogenic bacteria can communicate with each other through AI-2 QS to promote pathogenicity and drug resistance (<xref ref-type="bibr" rid="ref46">Roy et al., 2011</xref>). Biofilms, produced <italic>via</italic> QS, are an important reason for bacterial drug resistance. <italic>Pseudomonas aeruginosa</italic> can sense AI-2 produced by other bacteria, which regulates its production of virulence factors and formation of biofilms (<xref ref-type="bibr" rid="ref31">Li et al., 2015</xref>; <xref ref-type="bibr" rid="ref55">Wang et al., 2016b</xref>). Exogenous AI-2 can significantly increase <italic>P. aeruginosa</italic> biofilm formation (<xref ref-type="bibr" rid="ref30">Li et al., 2017</xref>). However, an AI-2 QSI (D-ribose) affected the sensation of PAO1 to AI-2 and decreased the biomass of a mixed bacterial biofilm (<xref ref-type="bibr" rid="ref55">Wang et al., 2016b</xref>). In this study, we found that <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 formed a mixed-species biofilm when co-cultured (<xref rid="fig2" ref-type="fig">Figure 2</xref>). Compound Str7410 inhibited QS between <italic>P. aeruginosa</italic> and <italic>S. aureus</italic>, thereby reducing the biofilm formation.</p>
<p>Nearly 80% of human infections are related to biofilms (<xref ref-type="bibr" rid="ref45">Romero et al., 2008</xref>; <xref ref-type="bibr" rid="ref59">Yan and Bassler, 2019</xref>). Meanwhile, the results of the present study showed that, compared with monoculture, co-culturing multiple species significantly reduced the effect of antibiotics (<xref rid="tab3" ref-type="table">Table 3</xref>). In addition, compared with planktonic cells, biofilm formation significantly increased bacterial resistance to antibiotics (<xref rid="tab3" ref-type="table">Table 3</xref>). Thus, the prevention and treatment of biofilms is a key concern of clinical staff and researchers (<xref ref-type="bibr" rid="ref48">Stewart and Costerton, 2001</xref>). Studies have found that QSI can increase the susceptibility of pathogenic biofilm cells to antibiotics (<xref ref-type="bibr" rid="ref9">Brackman et al., 2011</xref>; <xref ref-type="bibr" rid="ref21">Furiga et al., 2015</xref>; <xref ref-type="bibr" rid="ref49">Topa et al., 2020</xref>). Our study confirmed that compound Str7410 improved the susceptibility of a mixed-strain biofilm to the antibiotic MEPM, and that compound Str7410 can promote the inhibitory activities of antibiotics toward biofilm cells while having no effect on bacterial growth (<xref rid="fig1" ref-type="fig">Figure 1</xref>) and no eradication effect on the formed biofilm (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S1</xref>). Therefore, combining QSI with antibiotics is a new, and potentially highly effective, strategy for effective use of antibiotics against biofilm cells.</p>
<p>The nematode <italic>C. elegans</italic> is often used in <italic>in vivo</italic> models to study the pathogenicity of bacteria, for example, <italic>Serratia marcescens</italic>, <italic>P. aeruginosa</italic>, and <italic>Staphylococcus aureus</italic> (<xref ref-type="bibr" rid="ref42">Powell and Ausubel, 2008</xref>; <xref ref-type="bibr" rid="ref10">Brooks et al., 2009</xref>). The pathogenicity of co-infection with <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 toward <italic>C. elegans</italic> N2 was greater than that of either bacterial species alone. Compound Str7410 decreased the pathogenicity of the bacteria by inhibiting interspecific QS, thereby increasing the survival rate of infected nematodes (<xref rid="fig4" ref-type="fig">Figure 4</xref>). Thus, compound Str7410 can achieve a therapeutic effect in multispecies infections. Moreover, the combination of compound Str7410 with MEPM significantly increased the therapeutic effect of MEPM in infected nematodes.</p>
<p>We also evaluated the effect of compound Str7410 on the inhibition of interspecies QS <italic>via</italic> analysis of virulence factors of <italic>P. aeruginosa</italic>. Pyocyanin is a blue&#x2013;green phenazine pigment, which has a number of physiological roles, such as facilitating biofilm development and influencing colony formation, and it is also one of the causes of pulmonary infections caused by <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="ref57">Wilson et al., 1988</xref>; <xref ref-type="bibr" rid="ref17">Dietrich et al., 2006</xref>; <xref ref-type="bibr" rid="ref64">Zhu et al., 2019</xref>). <italic>Pseudomonas aeruginosa</italic> regulates the production of pyocyanin through two QS pathways, the <italic>rhl</italic> and <italic>pqs</italic> systems (<xref ref-type="bibr" rid="ref18">Diggle et al., 2003</xref>). Elastase destroys cellular tissues in infected hosts (<xref ref-type="bibr" rid="ref7">Ben Haj Khalifa et al., 2011</xref>). Elastase is regulated by the QS-related <italic>lasB</italic> gene. Bacterial motility plays a critical role in pathogenicity and antibiotic resistance. <italic>Pseudomonas aeruginosa</italic> swarming motility is mainly regulated by QS-related genes such as <italic>lasB</italic> and <italic>pvdQ</italic> (<xref ref-type="bibr" rid="ref50">Tremblay and Deziel, 2008</xref>). <italic>Pseudomonas aeruginosa</italic> can sense exogenous AI-2, which enhances the production of the virulence factors pyocyanin and elastase (<xref ref-type="bibr" rid="ref31">Li et al., 2015</xref>). The peptidoglycan produced by <italic>S. aureus</italic> can also enhance the production of pyocyanin and elastase by <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="ref29">Korgaonkar et al., 2013</xref>). Under normoxia, the supernatant of <italic>S. aureus</italic> can promote the swarming motility of <italic>P. aeruginosa</italic> PAO1 (<xref ref-type="bibr" rid="ref38">Pallett et al., 2019</xref>). In this study, we confirmed that the amount of pyocyanin and elastase produced by <italic>P. aeruginosa</italic> PAO1 significantly increased when <italic>P. aeruginosa</italic> and <italic>S. aureus</italic> were co-cultured (<xref rid="fig5" ref-type="fig">Figure 5</xref>), and <italic>S. aureus</italic> ATCC 25923 culture supernatant promoted the swarming motility of strain PAO1 (<xref rid="fig6" ref-type="fig">Figure 6B</xref>). Compound Str7410 significantly inhibited the virulence factor production and swarming motility of <italic>P. aeruginosa</italic> PAO1 during co-culture of <italic>P. aeruginosa</italic> PAO1 and <italic>S. aureus</italic> ATCC 25923 (<xref rid="fig5" ref-type="fig">Figures 5</xref>, <xref rid="fig6" ref-type="fig">6C</xref>). We suggest that compound Str7410 reduced the production of virulence factors and swarming motility by inhibiting the sensation of <italic>P. aeruginosa</italic> PAO1 to AI-2 signaling molecules.</p>
<p>As a general QS system possessed by both Gram-positive and Gram-negative bacteria, AI-2 QS boosts the coordination and communication between bacteria in bacterial infection (<xref ref-type="bibr" rid="ref19">Duan et al., 2003</xref>). <xref ref-type="bibr" rid="ref58">Woods et al. (2018)</xref> found that there is an interaction between <italic>P. aeruginosa</italic> and <italic>S. aureus</italic> in co-cultured bacterial biofilms, and <italic>S. aureus</italic> can increase the expression of QS-related genes of <italic>P. aeruginosa</italic>. Moreover, the presence of exogenous AI-2 signal molecules can upregulate the expression of <italic>P. aeruginosa</italic> QS-related genes (<xref ref-type="bibr" rid="ref31">Li et al., 2015</xref>). In this study (<xref rid="fig7" ref-type="fig">Figure 7</xref>), <italic>S. aureus</italic> ATCC 25923 significantly upregulated the expression of <italic>P. aeruginosa</italic> PAO1 QS-related genes (<italic>lasI</italic>, <italic>lasR</italic>, <italic>rhlI</italic>, <italic>rhlR</italic>, <italic>pqsH</italic>, and <italic>pqsR</italic>) and some QS target genes such as the virulence factor-related genes <italic>lasB</italic> and <italic>phzH</italic>. However, when compound Str7410 was added to the co-cultures, it reduced the pathogenicity of <italic>P. aeruginosa</italic> PAO1 by inhibiting the sensation of strain PAO1 to interspecific QS, thereby downregulating the expression of QS-related genes and the production of virulence factors.</p>
<p>In conclusion, this study focused on the inhibitory effects of a compound identified by virtual screening on the QS system of co-cultured Gram-positive bacterium <italic>S. aureus</italic> and Gram-negative bacterium <italic>P. aeruginosa in vitro</italic> and <italic>in vivo</italic>. Compound Str7410 was a potent AI-2 QSI. The combination of compound Str7410 with the antibiotic MEPM significantly increased the susceptibility of mixed-species-biofilm cells to the antibiotic. Preliminary mechanistic studies showed that Str7410 inhibited interspecific QS by inhibiting the AI-2 sensation of <italic>P. aeruginosa</italic> PAO1 and downregulating the expression of QS-related genes. This study provides a new strategy for the discovery of antibiotics in theory and a strategy for the clinical treatment of multidrug-resistant bacterial infections in practice.</p>
</sec>
<sec id="sec29" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref rid="sec50" ref-type="sec">Supplementary Material</xref>; further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="sec30">
<title>Author Contributions</title>
<p>FL and JX conceived and designed the experiments. KJ, YX, BY, YY, MZ, RL, HW, LW, and YZ performed the experiments. KJ and YX created the figures, analyzed the data, and wrote the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="sec31" sec-type="funding-information">
<title>Funding</title>
<p>This study was supported by the National Science and Technology Major Project of China (2018ZX09711003-003).</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec34" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec id="sec50" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2022.791802/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2022.791802/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_1.docx" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname> <given-names>R. C.</given-names></name> <name><surname>Popat</surname> <given-names>R.</given-names></name> <name><surname>Diggle</surname> <given-names>S. P.</given-names></name> <name><surname>Brown</surname> <given-names>S. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Targeting virulence: can we make evolution-proof drugs?</article-title> <source>Nat. Rev. Microbiol.</source> <volume>12</volume>, <fpage>300</fpage>&#x2013;<lpage>308</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro3232</pub-id>, PMID: <pub-id pub-id-type="pmid">24625893</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Armbruster</surname> <given-names>C. R.</given-names></name> <name><surname>Wolter</surname> <given-names>D. J.</given-names></name> <name><surname>Mishra</surname> <given-names>M.</given-names></name> <name><surname>Hayden</surname> <given-names>H. S.</given-names></name> <name><surname>Radey</surname> <given-names>M. C.</given-names></name> <name><surname>Merrihew</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title><italic>Staphylococcus aureus</italic> protein A mediates interspecies interactions at the cell surface of <italic>Pseudomonas aeruginosa</italic></article-title>. <source>MBio</source> <volume>7</volume>, <fpage>e00538</fpage>&#x2013;<lpage>e00516</lpage>. doi: <pub-id pub-id-type="doi">10.1128/mBio.00538-16</pub-id>, PMID: <pub-id pub-id-type="pmid">27222468</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Armijo</surname> <given-names>L. M.</given-names></name> <name><surname>Wawrzyniec</surname> <given-names>S. J.</given-names></name> <name><surname>Kopciuch</surname> <given-names>M.</given-names></name> <name><surname>Brandt</surname> <given-names>Y. I.</given-names></name> <name><surname>Rivera</surname> <given-names>A. C.</given-names></name> <name><surname>Withers</surname> <given-names>N. J.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against <italic>Pseudomonas aeruginosa</italic> biofilms</article-title>. <source>J. Nanobiotechnol.</source> <volume>18</volume>:<fpage>35</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12951-020-0588-6</pub-id>, PMID: <pub-id pub-id-type="pmid">32070354</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atalla</surname> <given-names>H.</given-names></name> <name><surname>Gyles</surname> <given-names>C.</given-names></name> <name><surname>Mallard</surname> <given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Staphylococcus aureus</italic> small colony variants (SCVs) and their role in disease</article-title>. <source>Anim. Health Res. Rev.</source> <volume>12</volume>, <fpage>33</fpage>&#x2013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S1466252311000065</pub-id>, PMID: <pub-id pub-id-type="pmid">21676339</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baldan</surname> <given-names>R.</given-names></name> <name><surname>Cigana</surname> <given-names>C.</given-names></name> <name><surname>Testa</surname> <given-names>F.</given-names></name> <name><surname>Bianconi</surname> <given-names>I.</given-names></name> <name><surname>De Simone</surname> <given-names>M.</given-names></name> <name><surname>Pellin</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Adaptation of <italic>Pseudomonas aeruginosa</italic> in cystic fibrosis airways influences virulence of <italic>Staphylococcus aureus</italic> in vitro and murine models of co-infection</article-title>. <source>PLoS One</source> <volume>9</volume>:<fpage>e89614</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0089614</pub-id>, PMID: <pub-id pub-id-type="pmid">24603807</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bassler</surname> <given-names>B. L.</given-names></name> <name><surname>Wright</surname> <given-names>M.</given-names></name> <name><surname>Stiverman</surname> <given-names>M. R.</given-names></name></person-group> (<year>1994</year>). <article-title>Multiple signalling systems controlling expression of luminescence in <italic>Vibrio harveyi</italic>: sequence and function of genes encoding a second sensory pathway</article-title>. <source>Mol. Microbiol.</source> <volume>13</volume>, <fpage>273</fpage>&#x2013;<lpage>286</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2958.1994.tb00422.x</pub-id>, PMID: <pub-id pub-id-type="pmid">7984107</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ben Haj Khalifa</surname> <given-names>A.</given-names></name> <name><surname>Moissenet</surname> <given-names>D.</given-names></name> <name><surname>Vu Thien</surname> <given-names>H.</given-names></name> <name><surname>Khedher</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Virulence factors in <italic>Pseudomonas aeruginosa</italic>: mechanisms and modes of regulation</article-title>. <source>Ann. Biol. Clin.</source> <volume>69</volume>, <fpage>393</fpage>&#x2013;<lpage>403</lpage>. doi: <pub-id pub-id-type="doi">10.1684/abc.2011.0589</pub-id>, PMID: <pub-id pub-id-type="pmid">21896403</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blanchard</surname> <given-names>A. C.</given-names></name> <name><surname>Waters</surname> <given-names>V. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Microbiology of cystic fibrosis airway disease</article-title>. <source>Semin. Respir. Crit. Care Med.</source> <volume>40</volume>, <fpage>727</fpage>&#x2013;<lpage>736</lpage>. doi: <pub-id pub-id-type="doi">10.1055/s-0039-1698464</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brackman</surname> <given-names>G.</given-names></name> <name><surname>Cos</surname> <given-names>P.</given-names></name> <name><surname>Maes</surname> <given-names>L.</given-names></name> <name><surname>Nelis</surname> <given-names>H. J.</given-names></name> <name><surname>Coenye</surname> <given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>2655</fpage>&#x2013;<lpage>2661</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00045-11</pub-id>, PMID: <pub-id pub-id-type="pmid">21422204</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname> <given-names>K. K.</given-names></name> <name><surname>Liang</surname> <given-names>B.</given-names></name> <name><surname>Watts</surname> <given-names>J. L.</given-names></name></person-group> (<year>2009</year>). <article-title>The influence of bacterial diet on fat storage in <italic>C. elegans</italic></article-title>. <source>PLoS One</source> <volume>4</volume>:<fpage>e7545</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0007545</pub-id>, PMID: <pub-id pub-id-type="pmid">19844570</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chbib</surname> <given-names>C.</given-names></name></person-group> (<year>2020</year>). <article-title>Impact of the structure-activity relationship of AHL analogues on quorum sensing in gram-negative bacteria</article-title>. <source>Bioorg. Med. Chem.</source> <volume>28</volume>:<fpage>115282</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bmc.2019.115282</pub-id>, PMID: <pub-id pub-id-type="pmid">31918952</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname> <given-names>K. C.</given-names></name> <name><surname>Tsuchikama</surname> <given-names>K.</given-names></name> <name><surname>Lowery</surname> <given-names>C. A.</given-names></name> <name><surname>Zhu</surname> <given-names>J.</given-names></name> <name><surname>Janda</surname> <given-names>K. D.</given-names></name></person-group> (<year>2015</year>). <article-title>Dissecting AI-2-mediated quorum sensing through C5-analogue synthesis and biochemical analysis</article-title>. <source>Tetrahedron</source> <volume>72</volume>, <fpage>3593</fpage>&#x2013;<lpage>3598</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tet.2015.08.063</pub-id>, PMID: <pub-id pub-id-type="pmid">27340303</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname> <given-names>C. A.</given-names></name> <name><surname>Esiobu</surname> <given-names>N.</given-names></name> <name><surname>Lopez</surname> <given-names>J. V.</given-names></name></person-group> (<year>2012</year>). <article-title>Co-cultures of <italic>Pseudomonas aeruginosa</italic> and <italic>Roseobacter denitrificans</italic> reveal shifts in gene expression levels compared to solo cultures</article-title>. <source>Sci. World J.</source> <volume>2012</volume>:<fpage>120108</fpage>. doi: <pub-id pub-id-type="doi">10.1100/2012/120108</pub-id>, PMID: <pub-id pub-id-type="pmid">22566756</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dalton</surname> <given-names>T.</given-names></name> <name><surname>Dowd</surname> <given-names>S. E.</given-names></name> <name><surname>Wolcott</surname> <given-names>R. D.</given-names></name> <name><surname>Sun</surname> <given-names>Y.</given-names></name> <name><surname>Watters</surname> <given-names>C.</given-names></name> <name><surname>Griswold</surname> <given-names>J. A.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>An <italic>in vivo</italic> polymicrobial biofilm wound infection model to study interspecies interactions</article-title>. <source>PLoS One</source> <volume>6</volume>:<fpage>e27317</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0027317</pub-id>, PMID: <pub-id pub-id-type="pmid">22076151</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeLeon</surname> <given-names>S.</given-names></name> <name><surname>Clinton</surname> <given-names>A.</given-names></name> <name><surname>Fowler</surname> <given-names>H.</given-names></name> <name><surname>Everett</surname> <given-names>J.</given-names></name> <name><surname>Horswill</surname> <given-names>A. R.</given-names></name> <name><surname>Rumbaugh</surname> <given-names>K. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Synergistic interactions of <italic>Pseudomonas aeruginosa</italic> and <italic>Staphylococcus aureus in vivo</italic> an <italic>in vitro</italic> wound model</article-title>. <source>Infect. Immun.</source> <volume>82</volume>, <fpage>4718</fpage>&#x2013;<lpage>4728</lpage>. doi: <pub-id pub-id-type="doi">10.1128/IAI.02198-14</pub-id>, PMID: <pub-id pub-id-type="pmid">25156721</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dietrich</surname> <given-names>L. E.</given-names></name> <name><surname>Price-Whelan</surname> <given-names>A.</given-names></name> <name><surname>Petersen</surname> <given-names>A.</given-names></name> <name><surname>Whiteley</surname> <given-names>M.</given-names></name> <name><surname>Newman</surname> <given-names>D. K.</given-names></name></person-group> (<year>2006</year>). <article-title>The phenazine pyocyanin is a terminal signalling factor in the quorum sensing network of <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Mol. Microbiol.</source> <volume>61</volume>, <fpage>1308</fpage>&#x2013;<lpage>1321</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05306.x</pub-id>, PMID: <pub-id pub-id-type="pmid">16879411</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diggle</surname> <given-names>S. P.</given-names></name> <name><surname>Winzer</surname> <given-names>K.</given-names></name> <name><surname>Chhabra</surname> <given-names>S. R.</given-names></name> <name><surname>Worrall</surname> <given-names>K. E.</given-names></name> <name><surname>Camara</surname> <given-names>M.</given-names></name> <name><surname>Williams</surname> <given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>The <italic>Pseudomonas aeruginosa</italic> quinolone signal molecule overcomes the cell density-dependency of the quorum sensing hierarchy, regulates rhl-dependent genes at the onset of stationary phase and can be produced in the absence of <italic>LasR</italic></article-title>. <source>Mol. Microbiol.</source> <volume>50</volume>, <fpage>29</fpage>&#x2013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03672.x</pub-id>, PMID: <pub-id pub-id-type="pmid">14507361</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname> <given-names>K.</given-names></name> <name><surname>Dammel</surname> <given-names>C.</given-names></name> <name><surname>Stein</surname> <given-names>J.</given-names></name> <name><surname>Rabin</surname> <given-names>H.</given-names></name> <name><surname>Surette</surname> <given-names>M. G.</given-names></name></person-group> (<year>2003</year>). <article-title>Modulation of <italic>Pseudomonas aeruginosa</italic> gene expression by host microflora through interspecies communication</article-title>. <source>Mol. Microbiol.</source> <volume>50</volume>, <fpage>1477</fpage>&#x2013;<lpage>1491</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03803.x</pub-id>, PMID: <pub-id pub-id-type="pmid">14651632</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Essar</surname> <given-names>D. W.</given-names></name> <name><surname>Eberly</surname> <given-names>L.</given-names></name> <name><surname>Hadero</surname> <given-names>A.</given-names></name> <name><surname>Crowford</surname> <given-names>I. P.</given-names></name></person-group> (<year>1990</year>). <article-title>Identification and characterization of genes for a second Anthranilate synthase in <italic>Pseudomonas aeruginosa</italic>: interchangeability of the two Anthranilate synthases and evolutionary implications</article-title>. <source>J. Bacteriol.</source> <volume>172</volume>, <fpage>884</fpage>&#x2013;<lpage>900</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.172.2.884-900.1990</pub-id>, PMID: <pub-id pub-id-type="pmid">2153661</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Furiga</surname> <given-names>A.</given-names></name> <name><surname>Lajoie</surname> <given-names>B.</given-names></name> <name><surname>Hage</surname> <given-names>E. I. S.</given-names></name> <name><surname>Baziard</surname> <given-names>G.</given-names></name> <name><surname>Roques</surname> <given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Impairment of <italic>Pseudomonas aeruginosa</italic> biofilm resistance to antibiotics by combining the drugs with a new quorum-sensing inhibitor</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>60</volume>, <fpage>1676</fpage>&#x2013;<lpage>1686</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.02533-15</pub-id>, PMID: <pub-id pub-id-type="pmid">26711774</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganin</surname> <given-names>H.</given-names></name> <name><surname>Tang</surname> <given-names>X.</given-names></name> <name><surname>Meijler</surname> <given-names>M. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Inhibition of <italic>Pseudomonas aeruginosa</italic> quorum sensing by AI-2 analogs</article-title>. <source>Bioorg. Med. Chem. Lett.</source> <volume>19</volume>, <fpage>3941</fpage>&#x2013;<lpage>3944</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bmcl.2009.03.163</pub-id>, PMID: <pub-id pub-id-type="pmid">19394822</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gokalsin</surname> <given-names>B.</given-names></name> <name><surname>Aksoydan</surname> <given-names>B.</given-names></name> <name><surname>Erman</surname> <given-names>B.</given-names></name> <name><surname>Sesal</surname> <given-names>N. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Reducing virulence and biofilm of <italic>Pseudomonas aeruginosa</italic> by potential quorum sensing inhibitor carotenoid: Zeaxanthin</article-title>. <source>Microb. Ecol.</source> <volume>74</volume>, <fpage>466</fpage>&#x2013;<lpage>473</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00248-017-0949-3</pub-id>, PMID: <pub-id pub-id-type="pmid">28255686</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>Q.</given-names></name> <name><surname>Wei</surname> <given-names>Y.</given-names></name> <name><surname>Xia</surname> <given-names>B.</given-names></name> <name><surname>Jin</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>C.</given-names></name> <name><surname>Pan</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Identification of a small molecule that simultaneously suppresses virulence and antibiotic resistance of <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Sci. Rep.</source> <volume>6</volume>:<fpage>19141</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep19141</pub-id>, PMID: <pub-id pub-id-type="pmid">26751736</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname> <given-names>F.</given-names></name></person-group> (<year>2007</year>). <article-title>Microbial ecology of the cystic fibrosis lung</article-title>. <source>Microbiology</source> <volume>153</volume>, <fpage>917</fpage>&#x2013;<lpage>923</lpage>. doi: <pub-id pub-id-type="doi">10.1099/mic.0.2006/004077-0</pub-id>, PMID: <pub-id pub-id-type="pmid">17379702</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hotterbeekx</surname> <given-names>A.</given-names></name> <name><surname>Kumar-Singh</surname> <given-names>S.</given-names></name> <name><surname>Goossens</surname> <given-names>H.</given-names></name> <name><surname>Malhotra-Kumar</surname> <given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title><italic>In vivo</italic> and <italic>in vitro</italic> interactions between <italic>Pseudomonas aeruginosa</italic> and <italic>staphylococcus</italic> spp</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>7</volume>:<fpage>106</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2017.00106</pub-id>, PMID: <pub-id pub-id-type="pmid">28421166</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>K.</given-names></name> <name><surname>Yan</surname> <given-names>X.</given-names></name> <name><surname>Yu</surname> <given-names>J.</given-names></name> <name><surname>Xiao</surname> <given-names>Z.</given-names></name> <name><surname>Wu</surname> <given-names>H.</given-names></name> <name><surname>Zhao</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Design, synthesis, and biological evaluation of 3-amino-2-oxazolidinone derivatives as potent quorum-sensing inhibitors of <italic>Pseudomonas aeruginosa</italic> PAO1</article-title>. <source>Eur. J. Med. Chem.</source> <volume>194</volume>:<fpage>112252</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejmech.2020.112252</pub-id>, PMID: <pub-id pub-id-type="pmid">32244097</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname> <given-names>V. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Quorum sensing inhibitors: an overview</article-title>. <source>Biotechnol. Adv.</source> <volume>31</volume>, <fpage>224</fpage>&#x2013;<lpage>245</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biotechadv.2012.10.004</pub-id>, PMID: <pub-id pub-id-type="pmid">23142623</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korgaonkar</surname> <given-names>A.</given-names></name> <name><surname>Trivedi</surname> <given-names>U.</given-names></name> <name><surname>Rumbaugh</surname> <given-names>K. P.</given-names></name> <name><surname>Whiteley</surname> <given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Community surveillance enhances <italic>Pseudomonas aeruginosa</italic> virulence during polymicrobial infection</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>110</volume>, <fpage>1059</fpage>&#x2013;<lpage>1064</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1214550110</pub-id>, PMID: <pub-id pub-id-type="pmid">23277552</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>X.</given-names></name> <name><surname>Song</surname> <given-names>C.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name> <name><surname>Liu</surname> <given-names>Z.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Autoinducer-2 facilitates <italic>Pseudomonas aeruginosa</italic> PAO1 pathogenicity <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source>Front. Microbiol.</source> <volume>8</volume>:<fpage>1944</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2017.01944</pub-id>, PMID: <pub-id pub-id-type="pmid">29089927</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>X.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name> <name><surname>Fu</surname> <given-names>Y.</given-names></name> <name><surname>Ai</surname> <given-names>Q.</given-names></name> <name><surname>Dong</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Autoinducer-2 regulates <italic>Pseudomonas aeruginosa</italic> PAO1 biofilm formation and virulence production in a dose-dependent manner</article-title>. <source>BMC Microbiol.</source> <volume>15</volume>:<fpage>192</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12866-015-0529-y</pub-id>, PMID: <pub-id pub-id-type="pmid">26420312</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lowery</surname> <given-names>C. A.</given-names></name> <name><surname>Abe</surname> <given-names>T.</given-names></name> <name><surname>Park</surname> <given-names>J.</given-names></name> <name><surname>Eubanks</surname> <given-names>L. M.</given-names></name> <name><surname>Sawada</surname> <given-names>D.</given-names></name> <name><surname>Kaufmann</surname> <given-names>G. F.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Revisiting AI-2 quorum sensing inhibitors: direct comparison of alkyl-DPD analogues and a natural product Fimbrolide</article-title>. <source>J. Am. Chem. Soc.</source> <volume>131</volume>, <fpage>15584</fpage>&#x2013;<lpage>15585</lpage>. doi: <pub-id pub-id-type="doi">10.1021/ja9066783</pub-id>, PMID: <pub-id pub-id-type="pmid">19824634</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lowery</surname> <given-names>C. A.</given-names></name> <name><surname>Park</surname> <given-names>J.</given-names></name> <name><surname>Kaufmann</surname> <given-names>G. F.</given-names></name> <name><surname>Janda</surname> <given-names>K. D.</given-names></name></person-group> (<year>2008</year>). <article-title>An unexpected switch in the modulation of AI-2-based quorum sensing discovered through synthetic 4,5-Dihydroxy-2,3-pentanedione analogues</article-title>. <source>J. Am. Chem. Soc.</source> <volume>130</volume>, <fpage>9200</fpage>&#x2013;<lpage>9201</lpage>. doi: <pub-id pub-id-type="doi">10.1021/ja802353j</pub-id>, PMID: <pub-id pub-id-type="pmid">18576653</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>R.</given-names></name> <name><surname>Qiu</surname> <given-names>S.</given-names></name> <name><surname>Jiang</surname> <given-names>Q.</given-names></name> <name><surname>Sun</surname> <given-names>H.</given-names></name> <name><surname>Xue</surname> <given-names>T.</given-names></name> <name><surname>Cai</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>AI-2 quorum sensing negatively regulates <italic>rbf</italic> expression and biofilm formation in <italic>Staphylococcus aureus</italic></article-title>. <source>Int. J. Med. Microbiol.</source> <volume>307</volume>, <fpage>257</fpage>&#x2013;<lpage>267</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijmm.2017.03.003</pub-id>, PMID: <pub-id pub-id-type="pmid">28416278</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mok</surname> <given-names>K. C.</given-names></name> <name><surname>Wingreen</surname> <given-names>N. S.</given-names></name> <name><surname>Bassler</surname> <given-names>B. L.</given-names></name></person-group> (<year>2003</year>). <article-title><italic>Vibrio harveyi</italic> quorum sensing: a coincidence detector for two autoinducers controls gene expression</article-title>. <source>EMBO J.</source> <volume>22</volume>, <fpage>870</fpage>&#x2013;<lpage>881</lpage>. doi: <pub-id pub-id-type="doi">10.1093/emboj/cdg085</pub-id>, PMID: <pub-id pub-id-type="pmid">12574123</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>A. T.</given-names></name> <name><surname>Oglesby-Sherrouse</surname> <given-names>A. G.</given-names></name></person-group> (<year>2016</year>). <article-title>Interactions between <italic>Pseudomonas aeruginosa</italic> and <italic>Staphylococcus aureus</italic> during co-cultivations and polymicrobial infections</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>100</volume>, <fpage>6141</fpage>&#x2013;<lpage>6148</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00253-016-7596-3</pub-id>, PMID: <pub-id pub-id-type="pmid">27236810</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orazi</surname> <given-names>G.</given-names></name> <name><surname>O&#x2019;Toole</surname> <given-names>G. A.</given-names></name></person-group> (<year>2017</year>). <article-title><italic>Pseudomonas aeruginosa</italic> alters <italic>Staphylococcus aureus</italic> sensitivity to vancomycin in a biofilm model of cystic fibrosis</article-title>. <source>Infection</source> <volume>8</volume>, <fpage>e00873</fpage>&#x2013;<lpage>e00817</lpage>. doi: <pub-id pub-id-type="doi">10.1128/mBio.00873-17</pub-id>, PMID: <pub-id pub-id-type="pmid">28720732</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pallett</surname> <given-names>R.</given-names></name> <name><surname>Leslie</surname> <given-names>L. J.</given-names></name> <name><surname>Lambert</surname> <given-names>P. A.</given-names></name> <name><surname>Milic</surname> <given-names>I.</given-names></name> <name><surname>Devitt</surname> <given-names>A.</given-names></name> <name><surname>Marshall</surname> <given-names>L. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Anaerobiosis influences virulence properties of <italic>Pseudomonas aeruginosa</italic> cystic fibrosis isolates and the interaction with <italic>Staphylococcus aureus</italic></article-title>. <source>Sci. Rep.</source> <volume>9</volume>:<fpage>6748</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-019-42952-x</pub-id>, PMID: <pub-id pub-id-type="pmid">31043640</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pastar</surname> <given-names>I.</given-names></name> <name><surname>Nusbaum</surname> <given-names>A. G.</given-names></name> <name><surname>Gil</surname> <given-names>J.</given-names></name> <name><surname>Patel</surname> <given-names>S. B.</given-names></name> <name><surname>Chen</surname> <given-names>J.</given-names></name> <name><surname>Valdes</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Interactions of methicillin resistant <italic>Staphylococcus aureus</italic> USA300 and <italic>Pseudomonas aeruginosa</italic> in polymicrobial wound infection</article-title>. <source>PLoS One</source> <volume>8</volume>:<fpage>e56846</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0056846</pub-id>, PMID: <pub-id pub-id-type="pmid">23451098</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname> <given-names>J. P.</given-names></name> <name><surname>Pesci</surname> <given-names>E. C.</given-names></name> <name><surname>Iglewski</surname> <given-names>B. H.</given-names></name></person-group> (<year>1997</year>). <article-title>Roles of <italic>Pseudomonas aeruginosa</italic> las and rhl quorum-sensing Systems in control of elastase and rhamnolipid biosynthesis genes</article-title>. <source>J. Bacteriol.</source> <volume>179</volume>, <fpage>5756</fpage>&#x2013;<lpage>5767</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.179.18.5756-5767.1997</pub-id>, PMID: <pub-id pub-id-type="pmid">9294432</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peeters</surname> <given-names>E.</given-names></name> <name><surname>Nelis</surname> <given-names>H. J.</given-names></name> <name><surname>Coenye</surname> <given-names>T.</given-names></name></person-group> (<year>2009</year>). <article-title><italic>In vitro</italic> activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>64</volume>, <fpage>801</fpage>&#x2013;<lpage>809</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkp253</pub-id>, PMID: <pub-id pub-id-type="pmid">19633000</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname> <given-names>J. R.</given-names></name> <name><surname>Ausubel</surname> <given-names>F. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Models of <italic>Caenorhabditis elegans</italic> infection by Bacterialand fungal pathogens</article-title>. <source>Methods Mol. Biol.</source> <volume>415</volume>, <fpage>403</fpage>&#x2013;<lpage>427</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-59745-570-1_24</pub-id>, PMID: <pub-id pub-id-type="pmid">18370168</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajkumari</surname> <given-names>J.</given-names></name> <name><surname>Borkotoky</surname> <given-names>S.</given-names></name> <name><surname>Murali</surname> <given-names>A.</given-names></name> <name><surname>Suchiang</surname> <given-names>K.</given-names></name> <name><surname>Mohanty</surname> <given-names>S. K.</given-names></name> <name><surname>Busi</surname> <given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Attenuation of quorum sensing controlled virulence factors and biofilm formation in <italic>Pseudomonas aeruginosa</italic> by pentacyclic triterpenes, betulin and betulinic acid</article-title>. <source>Microb. Pathog.</source> <volume>118</volume>, <fpage>48</fpage>&#x2013;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.micpath.2018.03.012</pub-id>, PMID: <pub-id pub-id-type="pmid">29526565</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname> <given-names>D.</given-names></name> <name><surname>Sims</surname> <given-names>J. J.</given-names></name> <name><surname>Wood</surname> <given-names>T. K.</given-names></name></person-group> (<year>2001</year>). <article-title>Inhibition of biofilm formation and swarming of Escherichia coli by (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone</article-title>. <source>Environ. Microbiol.</source> <volume>3</volume>, <fpage>731</fpage>&#x2013;<lpage>736</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1462-2920.2001.00249.x</pub-id>, PMID: <pub-id pub-id-type="pmid">11846763</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname> <given-names>R.</given-names></name> <name><surname>Schaudinn</surname> <given-names>C.</given-names></name> <name><surname>Kusanovic</surname> <given-names>J. P.</given-names></name> <name><surname>Gorur</surname> <given-names>A.</given-names></name> <name><surname>Gotsch</surname> <given-names>F.</given-names></name> <name><surname>Webster</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Detection of a microbial biofilm in intraamniotic infection</article-title>. <source>Am. J. Obstet. Gynecol.</source> <volume>198</volume>, <fpage>135.e1</fpage>&#x2013;<lpage>135.e5</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajog.2007.11.026</pub-id>, PMID: <pub-id pub-id-type="pmid">18166328</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname> <given-names>V.</given-names></name> <name><surname>Adams</surname> <given-names>B. L.</given-names></name> <name><surname>Bentley</surname> <given-names>W. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Developing next generation antimicrobials by intercepting AI-2 mediated quorum sensing</article-title>. <source>Enzym. Microb. Technol.</source> <volume>49</volume>, <fpage>113</fpage>&#x2013;<lpage>123</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.enzmictec.2011.06.001</pub-id>, PMID: <pub-id pub-id-type="pmid">22112397</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sifri</surname> <given-names>C. D.</given-names></name></person-group> (<year>2008</year>). <article-title>Healthcare epidemiology: quorum sensing: bacteria talk sense</article-title>. <source>Clin. Infect. Dis.</source> <volume>47</volume>, <fpage>1070</fpage>&#x2013;<lpage>1076</lpage>. doi: <pub-id pub-id-type="doi">10.1086/592072</pub-id>, PMID: <pub-id pub-id-type="pmid">18781869</pub-id></citation></ref>
<ref id="ref48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname> <given-names>P. S.</given-names></name> <name><surname>Costerton</surname> <given-names>J. W.</given-names></name></person-group> (<year>2001</year>). <article-title>Antibiotic resistance of bacteria in biofilms</article-title>. <source>Lancet</source> <volume>358</volume>, <fpage>135</fpage>&#x2013;<lpage>138</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0140-6736(01)0532-1</pub-id>, PMID: <pub-id pub-id-type="pmid">11463434</pub-id></citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Topa</surname> <given-names>S. H.</given-names></name> <name><surname>Palombo</surname> <given-names>E. A.</given-names></name> <name><surname>Kingshott</surname> <given-names>P.</given-names></name> <name><surname>Blackall</surname> <given-names>L. L.</given-names></name></person-group> (<year>2020</year>). <article-title>Activity of Cinnamaldehyde on quorum sensing and biofilm susceptibility to antibiotics in <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Microorganisms</source> <volume>8</volume>:<fpage>455</fpage>. doi: <pub-id pub-id-type="doi">10.3390/microorganisms8030455</pub-id>, PMID: <pub-id pub-id-type="pmid">32210139</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname> <given-names>J.</given-names></name> <name><surname>Deziel</surname> <given-names>E.</given-names></name></person-group> (<year>2008</year>). <article-title>Improving the reproducibility of <italic>Pseudomonas aeruginosa</italic> swarming motility assays</article-title>. <source>J. Basic Microbiol.</source> <volume>48</volume>, <fpage>509</fpage>&#x2013;<lpage>515</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jobm.200800030</pub-id>, PMID: <pub-id pub-id-type="pmid">18785657</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsukatani</surname> <given-names>T.</given-names></name> <name><surname>Kawaguchi</surname> <given-names>T.</given-names></name> <name><surname>Suenaga</surname> <given-names>H.</given-names></name> <name><surname>Shiga</surname> <given-names>M.</given-names></name> <name><surname>Ikegami</surname> <given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>Rapid and simple determination of minimum biofilm eradication concentration by a colorimetric microbial viability assay based on reduction of a water-tetrazolium salt and combinated effect of antibiotics against microbial biofilm</article-title>. <source>J. Microb. Biotech. Food</source> <volume>6</volume>, <fpage>677</fpage>&#x2013;<lpage>680</lpage>. doi: <pub-id pub-id-type="doi">10.15414/jmbfs.2016.6.1.677-680</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsukatani</surname> <given-names>T.</given-names></name> <name><surname>Sakata</surname> <given-names>F.</given-names></name> <name><surname>Kuroda</surname> <given-names>R.</given-names></name> <name><surname>Akao</surname> <given-names>R.</given-names></name></person-group> (<year>2020</year>). <article-title>Biofilm eradication activity of herb and spice extracts alone and in combination against oral and food-borne pathogenic bacteria</article-title>. <source>Curr. Microbiol.</source> <volume>77</volume>, <fpage>2486</fpage>&#x2013;<lpage>2495</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00284-020-02017-z</pub-id>, PMID: <pub-id pub-id-type="pmid">32394095</pub-id></citation></ref>
<ref id="ref001"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Delden</surname> <given-names>C.</given-names></name> <name><surname>Iglewski</surname> <given-names>B. H.</given-names></name></person-group> (<year>1998</year>). <article-title>Cell-to-Cell Signaling and Pseudomonas aeruginosa</article-title>. <source>Infections. Emerg. Infect. Dis.</source> <volume>4</volume>, <fpage>551</fpage>&#x2013;<lpage>560</lpage>. doi: <pub-id pub-id-type="doi">10.3201/eid0404.980405</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>S.</given-names></name> <name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Xie</surname> <given-names>S.</given-names></name> <name><surname>Wei</surname> <given-names>H.</given-names></name> <name><surname>Pan</surname> <given-names>Y.</given-names></name></person-group> (<year>2016a</year>). <article-title><italic>In vitro</italic> activities of doripenem against <italic>Pseudomonas aeruginosa</italic> biofilm</article-title>. <source>Chin. J. Antibiot.</source> <volume>41</volume>, <fpage>466</fpage>&#x2013;<lpage>476</lpage>. doi: <pub-id pub-id-type="doi">10.13461/j.cnki.cja.005756</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>B.</given-names></name> <name><surname>Grenier</surname> <given-names>D.</given-names></name> <name><surname>Yi</surname> <given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>Regulatory mechanisms of the LuxS/AI-2 system and bacterial resistance</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>63</volume>, <fpage>e01186</fpage>&#x2013;<lpage>e01119</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01186-19</pub-id>, PMID: <pub-id pub-id-type="pmid">31383657</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Z.</given-names></name> <name><surname>Xiang</surname> <given-names>Q.</given-names></name> <name><surname>Yang</surname> <given-names>T.</given-names></name> <name><surname>Li</surname> <given-names>L.</given-names></name> <name><surname>Yang</surname> <given-names>J.</given-names></name> <name><surname>Li</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2016b</year>). <article-title>Autoinducer-2 of <italic>Streptococcus mitis</italic> as a target molecule to inhibit pathogenic multi-species biofilm formation <italic>in vitro</italic> and in an endotracheal intubation rat model</article-title>. <source>Front. Microbiol.</source> <volume>7</volume>:<fpage>88</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2016.00088</pub-id>, PMID: <pub-id pub-id-type="pmid">26903968</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>P.</given-names></name> <name><surname>Camara</surname> <given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Quorum sensing and environmental adaptation in <italic>Pseudomonas aeruginosa</italic>: a tale of regulatory networks and multifunctional signal molecules</article-title>. <source>Curr. Opin. Microbiol.</source> <volume>12</volume>, <fpage>182</fpage>&#x2013;<lpage>191</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mib.2009.01.005</pub-id>, PMID: <pub-id pub-id-type="pmid">19249239</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>R.</given-names></name> <name><surname>Sykes</surname> <given-names>D. A.</given-names></name> <name><surname>Watson</surname> <given-names>D.</given-names></name> <name><surname>Rutman</surname> <given-names>A.</given-names></name> <name><surname>Taylor</surname> <given-names>G. W.</given-names></name> <name><surname>Cole</surname> <given-names>P. J.</given-names></name></person-group> (<year>1988</year>). <article-title>Measurement of <italic>Pseudomonas aeruginosa</italic> Phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium</article-title>. <source>Infect. Immun.</source> <volume>56</volume>, <fpage>2515</fpage>&#x2013;<lpage>2517</lpage>. doi: <pub-id pub-id-type="doi">10.1128/iai.56.9.2515-2517.1988</pub-id>, PMID: <pub-id pub-id-type="pmid">3137173</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname> <given-names>P. W.</given-names></name> <name><surname>Haynes</surname> <given-names>Z. M.</given-names></name> <name><surname>Mina</surname> <given-names>E. G.</given-names></name> <name><surname>Marques</surname> <given-names>C. N. H.</given-names></name></person-group> (<year>2018</year>). <article-title>Maintenance of <italic>S. aureus</italic> in co-culture with <italic>P. aeruginosa</italic> while growing as biofilms</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>:<fpage>3291</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2018.03291</pub-id>, PMID: <pub-id pub-id-type="pmid">30687276</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname> <given-names>J.</given-names></name> <name><surname>Bassler</surname> <given-names>B. L.</given-names></name></person-group> (<year>2019</year>). <article-title>Surviving as a community: antibiotic tolerance and persistence in bacterial biofilms</article-title>. <source>Cell Host Microbe</source> <volume>26</volume>, <fpage>15</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajog.2007.11.026</pub-id>, PMID: <pub-id pub-id-type="pmid">31295420</pub-id></citation></ref>
<ref id="ref60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>L.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Markussen</surname> <given-names>T.</given-names></name> <name><surname>Hoiby</surname> <given-names>N.</given-names></name> <name><surname>Tolker-Nielsen</surname> <given-names>T.</given-names></name> <name><surname>Molin</surname> <given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Pattern differentiation in co-culture biofilms formed by <italic>Staphylococcus aureus</italic> and <italic>Pseudomonas aeruginosa</italic></article-title>. <source>FEMS Immunol. Med. Microbiol.</source> <volume>62</volume>, <fpage>339</fpage>&#x2013;<lpage>347</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1574-695X.2011.00820.x</pub-id>, PMID: <pub-id pub-id-type="pmid">21595754</pub-id></citation></ref>
<ref id="ref61"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Yuan</surname> <given-names>B.</given-names></name></person-group> (<year>2019</year>). Design, Synthesis and Biological Activity of AI-2 Mediated Quorum Sensing Inhibitors in <italic>V. harveyi</italic>. MA thesis. Academy of Military Sciences, Beijing.</citation></ref>
<ref id="ref62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zang</surname> <given-names>T.</given-names></name> <name><surname>Lee</surname> <given-names>B. W.</given-names></name> <name><surname>Cannon</surname> <given-names>L. M.</given-names></name> <name><surname>Ritter</surname> <given-names>K. A.</given-names></name> <name><surname>Dai</surname> <given-names>S.</given-names></name> <name><surname>Ren</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>A naturally occurring brominated furanone covalently modifies and inactivates LuxS</article-title>. <source>Bioorg. Med. Chem. Lett.</source> <volume>19</volume>, <fpage>6200</fpage>&#x2013;<lpage>6204</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bmcl.2009.08.095</pub-id>, PMID: <pub-id pub-id-type="pmid">19775890</pub-id></citation></ref>
<ref id="ref63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>L.</given-names></name> <name><surname>Xue</surname> <given-names>T.</given-names></name> <name><surname>Shang</surname> <given-names>F.</given-names></name> <name><surname>Sun</surname> <given-names>H.</given-names></name> <name><surname>Sun</surname> <given-names>B.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Staphylococcus aureus</italic> AI-2 quorum sensing associates with the KdpDE two-component system to regulate capsular polysaccharide synthesis and virulence</article-title>. <source>Infect. Immun.</source> <volume>78</volume>, <fpage>3506</fpage>&#x2013;<lpage>3515</lpage>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00131-10</pub-id>, PMID: <pub-id pub-id-type="pmid">20498265</pub-id></citation></ref>
<ref id="ref64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>K.</given-names></name> <name><surname>Chen</surname> <given-names>S.</given-names></name> <name><surname>Sysoeva</surname> <given-names>T. A.</given-names></name> <name><surname>You</surname> <given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>Universal antibiotic tolerance arising from antibiotic-triggered accumulation of pyocyanin in <italic>Pseudomonas aeruginosa</italic></article-title>. <source>PLoS Biol.</source> <volume>17</volume>:<fpage>e3000573</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pbio.3000573</pub-id>, PMID: <pub-id pub-id-type="pmid">31841520</pub-id></citation></ref></ref-list></back></article>